var title_f40_56_41856="Neutropenic fever initial treatment";
var content_f40_56_41856=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F60657&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F60657&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 635px\">",
"   <div class=\"ttl\">",
"    Initial management of fever and neutropenia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 615px; height: 476px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ANC: absolute neutrophil count; C. difficile: Clostridium difficile.",
"     <br>",
"      * Fever in a neutropenic patient is defined as a single temperature &gt;38.3&deg;C (101&deg;F) or a sustained temperature &gt;38.0&deg;C (100.4&deg;F) for &gt;1 hour.",
"      <br>",
"       &Delta; The authors consider patients with an ANC &lt;500 cells/microL for &gt;7 days to be at high risk for serious complications. It should be noted that in the Infectious Diseases Society of America guidelines, patients with an absolute neutrophil count &le;100 cells/microL for &gt;7 days are considered to be at high risk for serious complications.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        Although ceftazidime monotherapy has been used for many years, we typically recommend using an alternative. See topic review for details.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52:e56. Copyright &copy; 2011 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41856=[""].join("\n");
var outline_f40_56_41856=null;
var title_f40_56_41857="Spontaneous pneumomediastinum in a young child";
var content_f40_56_41857=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Spontaneous pneumomediastinum in a young child",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 348px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows gas outlining inner surface of medlastinal pleura and aortlc arch (white arrows). This radiograph also demonstrates the \"spinnaker sign\", in which the thymic lobes are seen deviating upwards and outwards (arrowheads), a radiographic sign of pneumomediastinum that is seen only in infants and young children.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ibrahim Janahi&nbsp;and Ammar Saadoon.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41857=[""].join("\n");
var outline_f40_56_41857=null;
var title_f40_56_41858="Barretts esophagus diamine";
var content_f40_56_41858=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Barrett's esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 328px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a biopsy specimen from a patient with Barrett's esophagus has been stained with diamine. This stain demonstrates goblet cells containing sulfated mucins (brown) and nonsulfated mucins (blue).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 18, 1996, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41858=[""].join("\n");
var outline_f40_56_41858=null;
var title_f40_56_41859="Seborrheic keratosis vulva";
var content_f40_56_41859=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F70317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F70317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Seborrheic keratosis vulva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 330px; height: 412px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41859=[""].join("\n");
var outline_f40_56_41859=null;
var title_f40_56_41860="Norethindrone: Patient drug information";
var content_f40_56_41860=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Norethindrone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/52/16199?source=see_link\">",
"     see \"Norethindrone: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/60/9158?source=see_link\">",
"     see \"Norethindrone: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F202477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aygestin&reg;;",
"     </li>",
"     <li>",
"      Camila&reg;;",
"     </li>",
"     <li>",
"      Errin&reg;;",
"     </li>",
"     <li>",
"      Heather;",
"     </li>",
"     <li>",
"      Jolivette&reg;;",
"     </li>",
"     <li>",
"      Nor-QD&reg;;",
"     </li>",
"     <li>",
"      Nora-BE&reg;;",
"     </li>",
"     <li>",
"      Ortho Micronor&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F202478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Micronor&reg;;",
"     </li>",
"     <li>",
"      Norlutate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10025249\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700263",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug during the first 4 months of your pregnancy. Progestins may cause birth defects. Call your doctor if you think you may be pregnant. This drug does not stop the spread of diseases caused by having sex.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025251\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691546",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop pregnancy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691686",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat uterine bleeding due to hormonal imbalance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691832",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat endometriosis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691842",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat women who do not have a monthly period cycle.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to norethindrone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Blood clots, breast cancer, liver disease, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697269",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high cholesterol, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698612",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698231",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Period (menstrual) changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698598",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A lump in the breast or breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695799",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take tablet with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696559",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696550",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Missed dosing facts may be found in the package insert or call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11809 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.81.197.98-FD66CD12EC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41860=[""].join("\n");
var outline_f40_56_41860=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202477\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202478\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025249\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025251\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025250\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025255\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025256\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025258\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025253\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025254\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025259\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025260\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?15/52/16199?source=related_link\">",
"      Norethindrone: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/60/9158?source=related_link\">",
"      Norethindrone: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_56_41861="Acute esophageal necrosis (black esophagus)";
var content_f40_56_41861=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute esophageal necrosis (black esophagus)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41861/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41861/contributors\">",
"     Daniel S Mishkin, MDCM, FASGE, FACG, AGAF",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41861/contributors\">",
"     Daniel Gelrud, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41861/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41861/contributors\">",
"     Mark Feldman, MD, MACP, AGAF, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41861/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41861/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/56/41861/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute esophageal necrosis (AEN) has been referred to by multiple names including black esophagus, and necrotizing esophagitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. It is best described by the following criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute presentation with endoscopic findings consisting of a circumferential black esophagus with or without exudates.",
"     </li>",
"     <li>",
"      Distal esophageal involvement that can extend proximally, but ends sharply at the gastroesophageal border.",
"     </li>",
"     <li>",
"      Uniform histologic findings affecting the mucosa and submucosa and consisting of diffuse and severe necrosis, without recognizable stratified squamous cells, occasional deranged muscle fibers, hyperemia and scattered thrombosed vessels without specific causative agents.",
"     </li>",
"     <li>",
"      Occurrence in the absence of caustic or other injurious agents.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of AEN is incompletely understood. Its prevalence was estimated to be 0.2 percent in one autopsy study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/5\">",
"     5",
"    </a>",
"    ], while not a single case was identified in another autopsy study involving 1000 subjects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/6\">",
"     6",
"    </a>",
"    ]. In endoscopy series, the prevalence of AEN has been variably reported as ranging from 0.001 to 0.2 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/6-10\">",
"     6-10",
"    </a>",
"    ]. We identified 8 out of 3900 consecutive endoscopies at our institution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    AEN appears to be more common in men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/7,10\">",
"     7,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of AEN remains unknown, although ischemia likely has a role based upon histopathologic and clinical data [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In support of this hypothesis is the observation that temporary reduction of esophageal blood perfusion can result in extensive esophageal necrosis, which resolves rapidly when perfusion is restored [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/13\">",
"     13",
"    </a>",
"    ]. Furthermore, AEN tends to occur in the distal third of the esophagus, which is relatively hypovascular compared with other esophageal segments. Finally, the necrosis of the mucosa and submucosa, microscopic thrombosis and rapid regression are similar to the changes seen in ischemic colitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/20/42313?source=see_link\">",
"     \"Colonic ischemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gastric outlet obstruction has also been implicated in the pathogenesis of AEN [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/14\">",
"     14",
"    </a>",
"    ]. Regardless of cause, gastric outlet obstruction leads to an accumulation of fluid in the stomach, which can promote esophageal reflux. Exposure of the esophageal mucosa to acid could overwhelm the physiologic defense mechanisms resulting in direct injury with necrosis.",
"   </p>",
"   <p>",
"    AEN also has been associated with broad spectrum antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/15\">",
"     15",
"    </a>",
"    ], hyperglycemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/7\">",
"     7",
"    </a>",
"    ], underlying malignancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/7,10\">",
"     7,10",
"    </a>",
"    ], herpetic infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/16\">",
"     16",
"    </a>",
"    ], gastric volvulus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/17,18\">",
"     17,18",
"    </a>",
"    ], Stevens-Johnson syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/19\">",
"     19",
"    </a>",
"    ], after prolonged vomiting following alcohol binging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/20\">",
"     20",
"    </a>",
"    ], alcoholic lactic acidosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/21\">",
"     21",
"    </a>",
"    ], diabetic ketoacidosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/22\">",
"     22",
"    </a>",
"    ], following upper endoscopy and esophageal",
"    <span class=\"nowrap\">",
"     manometry/pHmetry",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/23\">",
"     23",
"    </a>",
"    ], a paraesophageal hernia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/24\">",
"     24",
"    </a>",
"    ], alcoholic hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/25\">",
"     25",
"    </a>",
"    ], and aortic dissection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is highly unlikely that a single etiologic factor is responsible for AEN. The presumed overall understanding is that of a \"two hit\" phenomenon. There is an initial event (ie, low flow vascular state), which then predisposes the esophageal mucosa to a severe topical injury (ie, reflux of acid and pepsin).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with AEN usually present with upper gastrointestinal bleeding sometimes developing rapidly following an inciting event (within 18 hours in one report) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/7,10,27\">",
"     7,10,27",
"    </a>",
"    ]. Patients may also have clinical features related to their underlying disorder (eg, a low flow state, gastric outlet obstruction, or the other conditions listed above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis is established with upper endoscopy. In the initial stages, the esophagus demonstrates the characteristic black discoloration (",
"    <a class=\"graphic graphic_picture graphicRef61519 \" href=\"mobipreview.htm?0/58/928\">",
"     picture 1",
"    </a>",
"    ) with underlying friable hemorrhagic tissue, and a sharp transition to normal-appearing mucosa at the gastroesophageal junction (",
"    <a class=\"graphic graphic_picture graphicRef74956 \" href=\"mobipreview.htm?42/44/43713\">",
"     picture 2",
"    </a>",
"    ). As noted above, predilection to the distal third of the esophagus is almost universal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/28\">",
"     28",
"    </a>",
"    ], although proximal involvement has been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/29\">",
"     29",
"    </a>",
"    ]. As the disease progresses, the esophagus may become partially covered with thick, white exudates that can be dislodged easily to reveal pink granulation tissue. These exudates most likely represent sloughed mucosal cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Biopsies should be obtained to differentiate AEN from other conditions in which the esophageal mucosa appears darkened (see below). Microscopic evaluation reveals severe necrosis of the mucosa and submucosa. Inflammation and partial destruction of adjacent muscle fibers may occasionally be seen and blood vessels are sometimes thrombosed or occluded. The rapid development of an eschar may protect the esophagus from complete penetration by whatever irritant is present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis includes several conditions in which the esophageal mucosa may also appear darkened or in which other gross findings can be similar.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Melanosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal melanosis has been described in patients with underlying chronic esophagitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. It is most commonly seen in the distal esophagus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Pseudomelanosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pseudomelanosis is due to tissue deposition of pseudomelanin, a \"wear and tear\" pigment derived from lysosomal degradation. Histologically it is seen as brown pigment within macrophages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Melanoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Melanoma of the esophagus is rare. It usually originates in the mid and lower esophagus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/34-36\">",
"     34-36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Acanthosis nigricans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acanthosis nigricans is characterized by velvety, verrucous, hyperpigmented skin and mucosal plaques. While it can be benign, it can also be a paraneoplastic phenomenon, commonly associated with intra-abdominal malignancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/18/21802?source=see_link\">",
"     \"Cutaneous manifestations of internal malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Coal dust and exogenous dye ingestion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coal dust or carbon is the most common exogenous pigment to deposit in human body tissues [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/39\">",
"     39",
"    </a>",
"    ]. The mechanism by which coal dust is deposited in the esophagus is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Pseudomembranous esophagitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pseudomembranous esophagitis has generally been reported in association with serious systemic illness. A thin, yellow or black, concentric membrane coats the distal (and less commonly entire) esophagus. The membrane can be dislodged revealing a friable underlying mucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/40\">",
"     40",
"    </a>",
"    ]. Some cases may represent a variant of acute esophageal necrosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial management should include adequate hydration and treatment of the underlying illness. Attempts to reduce topical insults to the esophagus include aggressive acid suppression, with intravenous proton pump inhibitors. Oral intake should be avoided for at least 24 hours after which",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/29/29141?source=see_link\">",
"     sucralfate",
"    </a>",
"    suspension should be considered because of its theoretical role in the prevention of further esophageal injury due to its cytoprotective effects and its ability to bind pepsin and stimulate mucus secretion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nasogastric tubes should be withheld unless used to decompress a gastric outlet obstruction or if persistent vomiting is present. A decision regarding antibiotics should be made on an individual basis, especially in the setting of patients who are critically ill or appear to be septic.",
"   </p>",
"   <p>",
"    The need for a repeat endoscopy should be guided by the patient's clinical course. As a general rule, the endoscopic findings revert to normal fairly rapidly. It is important to monitor for complications such as esophageal stenosis, which may present as dysphagia, and may require repeat endoscopy for diagnosis and therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The high mortality related to the underlying illnesses in patients with AEN (and the limited number of reported cases) obscures a detailed understanding of its natural history. One of the largest series included 25 patients of whom seven (35 percent) died of their underlying condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/7\">",
"     7",
"    </a>",
"    ]. In another series, 10 patients died (35 percent) but none as a direct consequence of the esophageal pathology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/8\">",
"     8",
"    </a>",
"    ]. Complications directly attributable to AEN were observed in five patients including four who developed an esophageal stricture and one who developed a mediastinal abscess. In another series of eight patients, three died while one developed esophageal stenosis requiring repeated dilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/10\">",
"     10",
"    </a>",
"    ]. In our series, 2 out of 10 patients (20 percent) died during the hospital admission when AEN was diagnosed, one of gastrointestinal bleeding related to AEN, another of multi-organ failure secondary to sepsis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41861/abstract/42\">",
"     42",
"    </a>",
"    ]. One patient developed a symptomatic esophageal stricture that was successfully treated with endoscopic dilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute esophageal necrosis is best described by the following criteria:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Acute presentation with endoscopic findings consisting of a circumferential black esophagus with or without exudates",
"     </li>",
"     <li>",
"      Distal esophageal involvement that can extend proximally, but ends sharply at the gastroesophageal border",
"     </li>",
"     <li>",
"      Uniform histologic findings affecting the mucosa and submucosa and consisting of diffuse and severe necrosis, without recognizable stratified squamous cells, occasional deranged muscle fibers, hyperemia and scattered thrombosed vessels without specific causative agents",
"     </li>",
"     <li>",
"      Occurrence in the absence of caustic or other injurious agents",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients typically present with upper gastrointestinal bleeding, and usually have an underlying predisposing condition, most commonly, hypotension or gastric outlet obstruction. Men are more commonly affected. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis is established by upper endoscopy during which biopsies should be obtained. The differential diagnosis includes miscellaneous conditions associated with esophageal pigmentation including melanosis, pseudomelanosis, acanthosis nigricans, malignant melanoma, and",
"      <span class=\"nowrap\">",
"       charcoal/dust",
"      </span>",
"      adsorption. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients should be treated with an intravenous proton pump inhibitor and be kept NPO for at least 24 hours after which",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/29/29141?source=see_link\">",
"       sucralfate",
"      </a>",
"      suspension should be considered. A nasogastric tube should be avoided unless patients are vomiting or have gastric outlet obstruction. Antibiotics should be considered on an individual patient basis usually depending on the severity and cause of the underlying illness. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients recover, although mortality rates from the underlying condition are approximately 20 to 35 percent in most series. The most common complication is esophageal stricture formation, which can be treated by dilation. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/1\">",
"      Brennan JL. Case of extensive necrosis of the oesophageal mucosa following hypothermia. J Clin Pathol 1967; 20:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/2\">",
"      Obermeyer R, Kasirajan K, Erzurum V, Chung D. Necrotizing esophagitis presenting as a black esophagus. Surg Endosc 1998; 12:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/3\">",
"      Geller A, Aguilar H, Burgart L, Gostout CJ. The black esophagus. Am J Gastroenterol 1995; 90:2210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/4\">",
"      Moret&oacute; M, Ojembarrena E, Zaballa M, et al. Idiopathic acute esophageal necrosis: not necessarily a terminal event. Endoscopy 1993; 25:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/5\">",
"      Etienne JP, Roge J, Delavierre P, Veyssier P. [Esophageal necrosis of vascular origin]. Sem Hop 1969; 45:1599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/6\">",
"      Postlethwait RW, Musser AW. Changes in the esophagus in 1,000 autopsy specimens. J Thorac Cardiovasc Surg 1974; 68:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/7\">",
"      Lacy BE, Toor A, Bensen SP, et al. Acute esophageal necrosis: report of two cases and a review of the literature. Gastrointest Endosc 1999; 49:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/8\">",
"      Augusto F, Fernandes V, Cremers MI, et al. Acute necrotizing esophagitis: a large retrospective case series. Endoscopy 2004; 36:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/9\">",
"      Juli&aacute;n G&oacute;mez L, Barrio J, Atienza R, et al. [Acute esophageal necrosis. An underdiagnosed disease]. Rev Esp Enferm Dig 2008; 100:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/10\">",
"      Ben Soussan E, Savoye G, Hochain P, et al. Acute esophageal necrosis: a 1-year prospective study. Gastrointest Endosc 2002; 56:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/11\">",
"      Goldenberg SP, Wain SL, Marignani P. Acute necrotizing esophagitis. Gastroenterology 1990; 98:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/12\">",
"      Jacobsen NO, Christiansen J, Kruse A. Incidence of oesophageal necrosis in an autopsy material. APMIS 2003; 111:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/13\">",
"      Haviv YS, Reinus C, Zimmerman J. \"Black esophagus\": a rare complication of shock. Am J Gastroenterol 1996; 91:2432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/14\">",
"      Reichart M, Busch OR, Bruno MJ, Van Lanschot JJ. Black esophagus: a view in the dark. Dis Esophagus 2000; 13:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/15\">",
"      Mangan TF, Colley AT, Wytock DH. Antibiotic-associated acute necrotizing esophagitis. Gastroenterology 1990; 99:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/16\">",
"      Cattan P, Cuillerier E, Cellier C, et al. Black esophagus associated with herpes esophagitis. Gastrointest Endosc 1999; 49:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/17\">",
"      Kram M, Gorenstein L, Eisen D, Cohen D. Acute esophageal necrosis associated with gastric volvulus. Gastrointest Endosc 2000; 51:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/18\">",
"      Matsumoto N, Oki E, Morita M, et al. Successful treatment of acute esophageal necrosis caused by intrathoracic gastric volvulus: report of a case. Surg Today 2009; 39:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/19\">",
"      Mah&eacute; A, K&eacute;ita S, Blanc L, Bobin P. Esophageal necrosis in the Stevens-Johnson syndrome. J Am Acad Dermatol 1993; 29:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/20\">",
"      Katsinelos P, Pilpilidis I, Dimiropoulos S, et al. Black esophagus induced by severe vomiting in a healthy young man. Surg Endosc 2003; 17:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/21\">",
"      Endo T, Sakamoto J, Sato K, et al. Acute esophageal necrosis caused by alcohol abuse. World J Gastroenterol 2005; 11:5568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/22\">",
"      Kim YH, Choi SY. Black esophagus with concomitant candidiasis developed after diabetic ketoacidosis. World J Gastroenterol 2007; 13:5662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/23\">",
"      Yamauchi J, Mitsufuji S, Taniguchi J, et al. Acute esophageal necrosis followed by upper endoscopy and esophageal manometry/pH test. Dig Dis Sci 2005; 50:1718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/24\">",
"      Hwang J, Weigel TL. Acute esophageal necrosis: \"black esophagus\". JSLS 2007; 11:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/25\">",
"      S��ftoiu A, Cazacu S, Kruse A, et al. Acute esophageal necrosis associated with alcoholic hepatitis: is it black or is it white? Endoscopy 2005; 37:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/26\">",
"      van de Wal-Visscher E, Nieuwenhuijzen GA, Nieuwenhuijsen GA, et al. Type B aortic dissection resulting in acute esophageal necrosis. Ann Vasc Surg 2011; 25:837.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/27\">",
"      Gurvits GE, Shapsis A, Lau N, et al. Acute esophageal necrosis: a rare syndrome. J Gastroenterol 2007; 42:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/28\">",
"      Gurvits GE, Robilotti JG. Isolated proximal black esophagus: etiology and the role of tissue biopsy. Gastrointest Endosc 2010; 71:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/29\">",
"      Neumann DA 2nd, Francis DL, Baron TH. Proximal black esophagus: a case report and review of the literature. Gastrointest Endosc 2009; 70:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/30\">",
"      Sharma SS, Venkateswaran S, Chacko A, Mathan M. Melanosis of the esophagus. An endoscopic, histochemical, and ultrastructural study. Gastroenterology 1991; 100:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/31\">",
"      Ohashi K, Kato Y, Kanno J, Kasuga T. Melanocytes and melanosis of the oesophagus in Japanese subjects--analysis of factors effecting their increase. Virchows Arch A Pathol Anat Histopathol 1990; 417:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/32\">",
"      Berry MA, DiPalma JA. Esophageal melanosis. J Clin Gastroenterol 1995; 21:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/33\">",
"      Kimball MW. Pseudomelanosis of the esophagus. Gastrointest Endosc 1978; 24:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/34\">",
"      Guzman RP, Wightman R, Ravinsky E, Unruh HW. Primary malignant melanoma of the esophagus with diffuse melanocytic atypia and melanoma in situ. Am J Clin Pathol 1989; 92:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/35\">",
"      DiCostanzo DP, Urmacher C. Primary malignant melanoma of the esophagus. Am J Surg Pathol 1987; 11:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/36\">",
"      Hulshof MC, Van Haaren PM, Zum V&ouml;rde Sive V&ouml;rding PJ, et al. Radiotherapy combined with hyperthermia for primary malignant melanomas of the esophagus. Dis Esophagus 2010; 23:E42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/37\">",
"      Kozlowski LM, Nigra TP. Esophageal acanthosis nigricans in association with adenocarcinoma from an unknown primary site. J Am Acad Dermatol 1992; 26:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/38\">",
"      Ramirez-Amador V, Esquivel-Pedraza L, Caballero-Mendoza E, et al. Oral manifestations as a hallmark of malignant acanthosis nigricans. J Oral Pathol Med 1999; 28:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/39\">",
"      Khan HA. Coal dust deposition--rare cause of \"black esophagus\". Am J Gastroenterol 1996; 91:2256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/40\">",
"      Nayyar AK, Royston C, Slater DN, Bardhan KD. Pseudomembranous esophagitis. Gastrointest Endosc 2001; 54:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/41\">",
"      Gurvits GE. Black esophagus: acute esophageal necrosis syndrome. World J Gastroenterol 2010; 16:3219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41861/abstract/42\">",
"      Gelrud D, Noyer C, Brenner S, Brandt LJ. Clinical outcomes of acute necrotizing esophagitis (abstract). Am J Gastroententerol 2000; 95:34.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2252 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.25.216.6-D91D1357DF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41861=[""].join("\n");
var outline_f40_56_41861=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Melanosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Pseudomelanosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Melanoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Acanthosis nigricans",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Coal dust and exogenous dye ingestion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Pseudomembranous esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2252\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2252|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/58/928\" title=\"picture 1\">",
"      Black esophagus Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/44/43713\" title=\"picture 2\">",
"      AEN GE junction Endosc",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/20/42313?source=related_link\">",
"      Colonic ischemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/18/21802?source=related_link\">",
"      Cutaneous manifestations of internal malignancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_56_41862="Sodium bicarbonate: Pediatric drug information";
var content_f40_56_41862=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sodium bicarbonate: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"    see \"Sodium bicarbonate: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/21/4437?source=see_link\">",
"    see \"Sodium bicarbonate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F221612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Brioschi&reg; [OTC];",
"     </li>",
"     <li>",
"      Neut&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1062178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Alkalinizing Agent, Oral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Alkalinizing Agent, Parenteral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antacid",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Electrolyte Supplement, Oral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Electrolyte Supplement, Parenteral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Sodium Salt",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11445044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Rapid administration at a high concentration may be associated with fluctuation in cerebral blood flow and possibly ICH; carefully consider clinical need before administering (Aschner, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolic  acidosis: Dosage should be based on the following formula if blood gases and pH measurements are available: HCO",
"     <sub>",
"      3",
"     </sub>",
"     <sup>",
"      -",
"     </sup>",
"     (mEq) = 0.3 x weight (kg) x base deficit (mEq/L)",
"     <b>",
"      or",
"     </b>",
"     HCO",
"     <sub>",
"      3",
"     </sub>",
"     <sup>",
"      -",
"     </sup>",
"     (mEq) = 0.5 x weight (kg) x [24 - serum HCO",
"     <sub>",
"      3",
"     </sub>",
"     <sup>",
"      -",
"     </sup>",
"     (mEq/L)]; usual dosage: 1-2 mEq/kg/dose (Berg, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     In 55 asphyxiated neonates, a fixed dose of 1.8 mEq/kg/dose over 3-5 minutes administered within first 5 minutes of life did not show clinical benefit (eg, survival, acid-base status, neurodevelopmental outcomes) compared to control group; further studies needed (Lokesh, 2004; Murki, 2004).",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1062172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"      see \"Sodium bicarbonate: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiac arrest: Patient should be adequately ventilated before administering NaHCO",
"     <sub>",
"      3",
"     </sub>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants: 1 mEq/kg slow IVP initially; may repeat with 0.5 mEq/kg in 10 minutes one time, or as indicated by the patient's acid-base status",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children and Adults: 1 mEq/kg IVP initially; may repeat with 0.5 mEq/kg in 10 minutes one time, or as indicated by the patient's acid-base status",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolic acidosis: Dosage should be based on the following formula if blood gases and pH measurements are available:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children: HCO",
"     <sub>",
"      3",
"     </sub>",
"     <sup>",
"      -",
"     </sup>",
"     (mEq) = 0.3 x weight (kg) x base deficit (mEq/L)",
"     <b>",
"      or",
"     </b>",
"     HCO",
"     <sub>",
"      3",
"     </sub>",
"     <sup>",
"      -",
"     </sup>",
"     (mEq) = 0.5 x weight (kg) x [24 - serum HCO",
"     <sub>",
"      3",
"     </sub>",
"     <sup>",
"      -",
"     </sup>",
"     (mEq/L)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: HCO",
"     <sub>",
"      3",
"     </sub>",
"     <sup>",
"      -",
"     </sup>",
"     (mEq) = 0.2 x weight (kg) x base deficit (mEq/L)",
"     <b>",
"      or",
"     </b>",
"     HCO",
"     <sub>",
"      3",
"     </sub>",
"     <sup>",
"      -",
"     </sup>",
"     (mEq) = 0.5 x weight (kg) x [24 - serum HCO",
"     <sub>",
"      3",
"     </sub>",
"     <sup>",
"      -",
"     </sup>",
"     (mEq/L)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     If acid-base status is not available: Dose for older Children and Adults: 2-5 mEq/kg I.V. infusion over 4-8 hours; subsequent doses should be based on patient's acid-base status",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Prevention of hyperuricemia secondary to tumor lysis syndrome (urinary alkalinization) (refer to individual protocols):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     I.V.: 120-200 mEq/m",
"     <sup>",
"      2",
"     </sup>",
"     /day diluted in maintenance I.V. fluids of 3000 mL/m",
"     <sup>",
"      2",
"     </sup>",
"     /day; titrate to maintain urine pH between 6-7",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: 12 g/m",
"     <sup>",
"      2",
"     </sup>",
"     /day divided into 4 doses; titrate to maintain urine pH between 6-7",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Chronic renal failure: Oral: Initiate when plasma HCO",
"     <sub>",
"      3",
"     </sub>",
"     <sup>",
"      -",
"     </sup>",
"     &lt;15 mEq/L:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 1-3 mEq/kg/day in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 20-36 mEq/day in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal tubular acidosis: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Distal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children: 2-3 mEq/kg/day in divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 0.5-2 mEq/kg/day given in 4-5 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Proximal: Children and Adults: Initial: 5-10 mEq/kg/day in divided doses; maintenance: Increase as required to maintain serum bicarbonate in the normal range",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Urine alkalinization: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 1-10 mEq (84-840 mg)/kg/day in divided doses; dose should be titrated to desired urinary pH",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 48 mEq (4 g) initially, then 12-24 mEq (1-2 g) every 4 hours; dose should be titrated to desired urinary pH; doses up to 16 g/day have been used",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Antacid: Oral: Adults: 325 mg to 2 grams 1-4 times/day",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F221592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Granules for solution, oral [effervescent]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Brioschi&reg;: 2.69 g/capful (120 g, 240 g) [contains sodium 770 mg/capful; lemon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Brioschi&reg;: 2.69 g/packet (12s) [contains sodium 770 mg/packet; lemon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 4.2% [5 mEq/10 mL] (10 mL); 8.4% [10 mEq/10 mL] (50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neut&reg;: 4% [2.4 mEq/5 mL] (5 mL) [contains edetate disodium]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 4.2% [5 mEq/10 mL] (5 mL); 7.5% [8.92 mEq/10 mL] (50 mL); 8.4% [10 mEq/10 mL] (10 mL, 50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder, oral: USP: 100% (120 g, 480 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 325 mg [3.8 mEq], 650 mg [7.6 mEq]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F221578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes granules",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1062182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Administer 1-3 hours after meals",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: For direct I.V. administration: In neonates and infants, use the 0.5 mEq/mL solution or dilute the 1 mEq/mL solution 1:1 with",
"     <b>",
"      SWI",
"     </b>",
"     ; in children and adults, the 1 mEq/mL solution may be used; administer slowly (maximum rate in neonates and infants: 10 mEq/minute); for infusion, dilute to a maximum concentration of 0.5 mEq/mL in dextrose solution and infuse over 2 hours (maximum rate of administration: 1 mEq/kg/hour)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F221645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS;",
"     <b>",
"      incompatible",
"     </b>",
"     with acids, acidic salts, alkaloid salts, calcium salts, catecholamines, and atropine;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in D",
"     <sub>",
"      5",
"     </sub>",
"     LR, LR, fat emulsion 10%, TPN.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, amifostine, asparaginase, aztreonam, bivalirudin, caffeine citrate, cefepime, ceftriaxone, cladribine, cyclophosphamide, cytarabine, daunorubicin, dexamethasone sodium phosphate, dexmedetomidine, docetaxel, doripenem, doxorubicin, etoposide, etoposide phosphate, famotidine, fentanyl, filgrastim, fludarabine, furosemide, gallium nitrate, gemcitabine, granisetron, heparin, heparin with hydrocortisone sodium succinate, ifosfamide, indomethacin, insulin (regular), levofloxacin, linezolid, melphalan, mesna, methylprednisolone sodium succinate, milrinone, morphine, oxaliplatin, paclitaxel, pancuronium, pemetrexed, piperacillin/tazobactam, potassium chloride, propofol, remifentanil, tacrolimus, telavancin, teniposide, thiotepa, tolazoline, vancomycin, vasopressin, vitamin B complex with C.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Allopurinol, amiodarone, amphotericin B cholesteryl sulfate complex, anidulafungin, calcium chloride, doxorubicin liposome, fenoldopam, hetastarch in lactate electrolyte injection (Hextend&reg;), idarubicin, imipenem/cilastatin, inamrinone, leucovorin calcium, midazolam, nalbuphine, ondansetron, oxacillin, sargramostim, verapamil, vincristine, vinorelbine.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ciprofloxacin, cisatracurium, diltiazem, pantoprazole, TPN.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Caffeine citrate, milrinone, pentobarbital.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Dimenhydrinate, glycopyrrolate, mepivacaine, metoclopramide, pantoprazole, thiopental.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Bupivacaine, chloroprocaine, lidocaine.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1062175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not mix NaHCO",
"     <sub>",
"      3",
"     </sub>",
"     with calcium salts, catecholamines, atropine",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1062181\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of metabolic acidosis; antacid; alkalinization of urine; stabilization of acid base status in cardiac arrest and treatment of life-threatening hyperkalemia",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F221644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Cerebral hemorrhage, CHF (aggravated), edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Tetany",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Belching, flatulence (with oral), gastric distension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypernatremia, hyperosmolality, hypocalcemia, hypokalemia, increased affinity of hemoglobin for oxygen-reduced pH in myocardial tissue necrosis when extravasated, intracranial acidosis, metabolic alkalosis, milk-alkali syndrome (especially with renal dysfunction)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Pulmonary edema",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1062186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to sodium bicarbonate or any component; alkalosis, hypocalcemia, hypernatremia; unknown abdominal pain, inadequate ventilation during cardiopulmonary resuscitation; excessive chloride losses",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1062171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with CHF or other sodium-retaining conditions and renal insufficiency. Rapid administration of hyperosmotic solution in neonates, infants, and children &lt;2 years of age has led to hypernatremia, decreased CSF pressure, and intracranial hemorrhage.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1062170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid extravasation, tissue necrosis can occur due to the hypertonicity of NaHCO",
"     <sub>",
"      3",
"     </sub>",
"     ; use of I.V. NaHCO",
"     <sub>",
"      3",
"     </sub>",
"     should be reserved for documented metabolic acidosis and for life-threatening hyperkalemia; routine use in cardiac arrest is not recommended; patient should be adequately ventilated before administering in cardiac arrest; administration of excessive amounts of sodium bicarbonate may result in metabolic alkalosis which decreases the delivery of oxygen to tissues; monitor use closely",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300051\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F221587\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Antacids may decrease the serum concentration of ACE Inhibitors.  Management: Separate fosinopril administration from antacids by at least 2 hours. US and Canadian recommendations for use of other ACE- inhibitors with antacids may vary. Consult appropriate labeling. Monitor for decreased therapeutic effects of ACE-inhibitors.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Enalaprilat; Ramipril.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AcetaZOLAMIDE: May enhance the adverse/toxic effect of Sodium Bicarbonate. Specifically, the risk of renal calculus formation may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists: Antacids may decrease the excretion of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Alkalinizing Agents may decrease the excretion of Amphetamines.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antacids may decrease the excretion of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticonvulsants (Hydantoin): Antacids may decrease the serum concentration of Anticonvulsants (Hydantoin).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): Antacids may decrease the absorption of Antipsychotic Agents (Phenothiazines).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atazanavir: Antacids may decrease the absorption of Atazanavir.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisacodyl: Antacids may diminish the therapeutic effect of Bisacodyl. Antacids may cause the delayed-release bisacodyl tablets to release drug prior to reaching the large intestine.  Gastric irritation and/or cramps may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: Antacids may decrease the serum concentration of Bosutinib.  Management: Administer antacids more than 2 hours before or after bosutinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Polystyrene Sulfonate: Antacids may enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the cation exchange resin.  Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of CPS effects. Avoid magnesium hydroxide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefditoren: Antacids may decrease the serum concentration of Cefditoren.  Management: Concomitant use of cefditoren with antacids is not recommended. Consider alternative methods to control acid reflux (eg, diet modification) or alternative antimicrobial therapy. If antacid therapy can not be avoided, separate dosing by several hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefpodoxime: Antacids may decrease the serum concentration of Cefpodoxime.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cefuroxime: Antacids may decrease the serum concentration of Cefuroxime.  Management:  Consider administering antacids and cefuroxime at least 2 hours apart.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloroquine: Antacids may decrease the serum concentration of Chloroquine.  Management: Separate administration of antacids and chloroquine by at least 4 hours to minimize any potential negative impact of antacids on chloroquine bioavailability.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Oral): Antacids may decrease the bioavailability of Corticosteroids (Oral).  Management: Consider separating doses by 2 or more hours. Budesonide enteric coated tablets could dissolve prematurely if given with drugs that lower gastric acid, with unknown impact on budesonide therapeutic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Antacids may decrease the serum concentration of Dabigatran Etexilate.  Management: Dabigatran etexilate Canadian product labeling recommends avoiding concomitant use with antacids for 24 hours after surgery. In other situations, administer dabigatran etexilate 2 hours prior to antacids. Monitor clinical response to dabigatran therapy.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: Antacids may decrease the absorption of Dasatinib.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Delavirdine: Antacids may decrease the serum concentration of Delavirdine.  Management: Separate doses of delavirdine and antacids by at least 1 hour. Monitor for decreased delavirdine therapeutic effects with this combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dexmethylphenidate: Antacids may increase the absorption of Dexmethylphenidate. Specifically, antacids may interfere with the normal release of drug from the extended-release capsules (Focalin XR brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elvitegravir: Antacids may decrease the serum concentration of Elvitegravir.  Management: Separate administration of antacids and the elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate combination product by at least 2 hours in order to minimize the risk for an interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Erlotinib: Antacids may decrease the serum concentration of Erlotinib.  Management: Separate the administration of erlotinib and any antacid by several hours in order to minimize the risk of a significant interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Flecainide: Sodium Bicarbonate may diminish the arrhythmogenic effect of Flecainide. Sodium Bicarbonate may increase the serum concentration of Flecainide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gabapentin: Antacids may decrease the serum concentration of Gabapentin.  Management: Administer gabapentin at least 2 hours after antacid administration.  Monitor patients closely for evidence of reduced response to gabapentin therapy when both of these drugs are being used.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HMG-CoA Reductase Inhibitors: Antacids may decrease the serum concentration of HMG-CoA Reductase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: Antacids may decrease the absorption of Iron Salts.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferric Gluconate; Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: Antacids may decrease the absorption of Isoniazid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Itraconazole: Antacids may decrease the serum concentration of Itraconazole.  Management: Administer itraconazole at least 1 hour after and 2 hours before administration of any antacids.  Itraconazole oral suspension may be less sensitive to the effects of decreased gastric acidity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketoconazole (Systemic): Antacids may decrease the serum concentration of Ketoconazole (Systemic).  Management: Administer oral ketoconazole at least 2 hours prior to use of any antacid product.  Monitor patients closely for signs of inadequate clinical response to ketoconazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Sodium Bicarbonate may increase the excretion of Lithium.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Memantine: Sodium Bicarbonate may decrease the excretion of Memantine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mesalamine: Antacids may diminish the therapeutic effect of Mesalamine. Antacid-mediated increases in gastrointestinal pH may cause the premature release of mesalamine from specific sustained-release mesalamine products.  Management: Avoid concurrent administration of antacids with sustained-release mesalamine products.  Separating antacid and mesalamine administration, and/or using lower antacid doses may be adequate means of avoiding this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methenamine: Antacids may diminish the therapeutic effect of Methenamine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antacids may increase the absorption of Methylphenidate. Specifically, antacids may interfere with the normal release of drug from the extended-release capsules (Ritalin LA brand), which could result in both increased absorption (early) and decreased delayed absorption.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Antacids may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, antacids may decrease the absorption of orally administered iron.  Management: Separate dosing of oral iron-containing multivitamin preparations and antacids by as much time as possible in order to minimize impact on therapeutic efficacy of the iron preparation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nilotinib: Antacids may decrease the serum concentration of Nilotinib.  Management: Separate the administration of nilotinib and any antacid by several hours whenever possible in order to minimize the risk of a significant interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PenicillAMINE: Antacids may decrease the serum concentration of PenicillAMINE.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Antacids may decrease the absorption of Phosphate Supplements.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ponatinib: Antacids may decrease the serum concentration of Ponatinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: Antacids may decrease the absorption of Protease Inhibitors.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Darunavir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Antacids may decrease the excretion of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNINE: Alkalinizing Agents may increase the serum concentration of QuiNINE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rilpivirine: Antacids may decrease the serum concentration of Rilpivirine.  Management: Administer antacids at least 2 hours before or 4 hours after rilpivirine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Antacids may decrease the absorption of Tetracycline Derivatives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Antacids may decrease the absorption of Trientine.  Management: Separate trientine dosing from other oral drugs (eg, antacids) by at least 1 hour. Monitor for decreased therapeutic effects of trientine if an antacid is initiated/dose increased, or increased effects if an antacid is discontinued/dose decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vismodegib: Antacids may decrease the serum concentration of Vismodegib.  Management: Carefully consider the need for any medication that increases the pH of the upper GI tract (PPIs, H2RAs, antacids), as these could significantly reduce vismodegib systemic exposure. Vismodegib dose increases are unlikely to compensate for this effect.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F221589\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13888241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. The use of sodium bicarbonate in pregnant women for the management of cardiac arrest and metabolic acidosis is the same as in nonpregnant women (Campbell, 2009; Vanden Hoek, 2010). Antacids containing sodium bicarbonate should not be used during pregnancy due to their potential to cause metabolic alkalosis and fluid overload (Mahadevan, 2007).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1062177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum electrolytes including calcium, urinary pH, arterial blood gases (if indicated)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1062169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dissociates to provide bicarbonate ion which neutralizes hydrogen ion concentration and raises blood and urinary pH",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1062184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral, as antacid: 15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 1-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 8-10 minutes",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1062185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Reabsorbed by kidney and &lt;1% is excreted in urine",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1062187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     1 mEq NaHCO",
"     <sub>",
"      3",
"     </sub>",
"     is equivalent to 84 mg; each g of NaHCO",
"     <sub>",
"      3",
"     </sub>",
"     provides 12 mEq each of sodium and bicarbonate ions; the osmolarity of 0.5 mEq/mL is 1000 mOsm/L and 1 mEq/mL is 2000 mOsm/L",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aschner JL and Poland RL, \"Sodium Bicarbonate: Basically Useless Therapy,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008, 122(4):831-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/56/41862/abstract-text/18829808/pubmed\" id=\"18829808\" target=\"_blank\">",
"        18829808",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Berg CS, Barnette AR, Myers BJ, et al, \"Sodium Bicarbonate Administration and Outcome in Preterm Infants,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2010, 157(4):684-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/56/41862/abstract-text/20580021/pubmed\" id=\"20580021\" target=\"_blank\">",
"        20580021",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lokesh L, Kumar P, Murki S, et al, \"A Randomized Controlled Trial of Sodium Bicarbonate in Neonatal Resuscitation-Effect on Immediate Outcome,\"",
"      <i>",
"       Resuscitation",
"      </i>",
"      , 2004, 60(2):219-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/56/41862/abstract-text/15036741/pubmed\" id=\"15036741\" target=\"_blank\">",
"        15036741",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Murki S, Kumar P, Lingappa L, et al, \"Effect of a Single Dose of Sodium Bicarbonate Given During Neonatal Resuscitation at Birth on the Acid-Base Status on First Day of Life,\"",
"      <i>",
"       J Perinatol",
"      </i>",
"      , 2004, 24(11):696-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?40/56/41862/abstract-text/15318251/pubmed\" id=\"15318251\" target=\"_blank\">",
"        15318251",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12795 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-217.117.136.88-094BD8D684-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41862=[""].join("\n");
var outline_f40_56_41862=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221612\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062178\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11445044\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062172\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221592\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221578\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062182\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221645\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062175\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062181\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221644\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062186\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062171\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062170\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300051\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221587\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221589\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13888241\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062177\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062169\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062184\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062185\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1062187\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12795\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12795|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=related_link\">",
"      Sodium bicarbonate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/21/4437?source=related_link\">",
"      Sodium bicarbonate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_56_41863="Phenytoin poisoning";
var content_f40_56_41863=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Phenytoin poisoning",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41863/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41863/contributors\">",
"     Mark Su, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41863/contributors\">",
"     Allon Amitai, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41863/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41863/contributors\">",
"     Stephen J Traub, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41863/contributors\">",
"     Michele Burns Ewald, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41863/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41863/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/56/41863/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    (eg, Dilantin&reg;) is an anticonvulsant used to treat many seizure disorders. It is also a Vaughan-Williams class IB antiarrhythmic agent, although it is now infrequently used for that indication.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    toxicity is rarely fatal, but can cause neurologic symptoms ranging from nystagmus to ataxia to coma.",
"   </p>",
"   <p>",
"    The basic pharmacology, presentation, and management of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    toxicity will be reviewed here. The clinical use of phenytoin to treat epilepsy and general issues concerning management of the poisoned patient are discussed elsewhere. A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef56499 \" href=\"mobipreview.htm?37/18/38188\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40570?source=see_link\">",
"     \"Overview of the management of epilepsy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    toxicity is associated with few serious adverse events or fatalities. According to the 2008 Annual Report of the American Association of Poison Control Centers (AAPCC) National Poison Data System, 2337 single-substance phenytoin exposures resulted in only 48 major outcomes and no deaths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/1\">",
"     1",
"    </a>",
"    ]. There were two reported fatalities in cases of multiple-substance exposures in which phenytoin was deemed either responsible or contributory. This low incidence of major outcomes and deaths is similar to that seen in previous years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/51/14138?source=see_link\">",
"     Fosphenytoin",
"    </a>",
"    , a prodrug of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , is believed to have fewer adverse effects than phenytoin. However, there were 29 cases of cardiac events related to fosphenytoin infusion reported to the United States (US) Food and Drug Administration (FDA) between 1997 and 2002 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/3\">",
"     3",
"    </a>",
"    ]. Ten of these resulted in death. Arrhythmias included bradycardia, high degree AV block, and sinus arrest. It is unclear how many of these dysrhythmias can be directly attributed to fosphenytoin, since many of these patients had significant preexisting cardiac pathology or were presumed to be in a state of cardiac stress from status epilepticus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    binds and inhibits voltage-dependent sodium channels, which are found on both neuronal and cardiac tissue. The increased membrane threshold for depolarization after sodium channel blockade lowers the susceptibility of neuronal tissue to epileptogenic stimuli. Excessive inhibition, however, may compromise normal cerebral function, leading to the incoordination and altered mental status characteristic of both acute and chronic phenytoin toxicity.",
"   </p>",
"   <p>",
"    Inhibition of sodium channels in cardiac tissue reduces the risk of arrhythmia.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    shortens cardiac action potentials and prolongs the refractory period between them. Cardiac effects such as dysrhythmias and SA and AV nodal blockade have been reported, especially following intravenous administration of phenytoin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Oral phenytoin has only rarely been reported to cause cardiac complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    is diluted in parenteral formulations using propylene glycol, which may cause toxicity, including hypotension and cardiac dysrhythmias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PHARMACOKINETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    is 70 percent bioavailable after oral ingestion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/8\">",
"     8",
"    </a>",
"    ]. The volume of distribution is approximately 0.5 to 0.8",
"    <span class=\"nowrap\">",
"     L/kg,",
"    </span>",
"    with significant protein binding (to albumin) in vivo. Phenytoin may be displaced from plasma proteins by many drugs, which can result in toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. At higher serum concentrations of phenytoin, protein binding saturates and free phenytoin concentrations (which determine toxicity) increase dramatically with only modest increases in overall phenytoin concentrations. This is important to bear in mind when interpreting toxic serum phenytoin concentrations. A list of drugs that alter serum phenytoin concentrations is provided (",
"    <a class=\"graphic graphic_table graphicRef82330 \" href=\"mobipreview.htm?34/38/35435\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Laboratory evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    metabolism varies depending upon its serum concentration. Hydroxylation by the cytochrome p450 system is the critical step [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/11\">",
"     11",
"    </a>",
"    ]. Metabolism follows first-order kinetics in the therapeutic range and mild overdoses, meaning that a fixed percentage of phenytoin is eliminated over a given period. At higher concentrations, the cytochrome p450 enzyme system becomes saturated, leading to zero-order kinetics in which a fixed amount of phenytoin is eliminated over a given period. This results in a prolonged half-life (24 to 230 hours in overdose) and contributes to increased serum concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The metabolism of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    is affected by many substances that interact with the cytochrome p450 system. A large number of drug-drug interactions will either raise or lower serum phenytoin concentrations, depending upon whether they induce or inhibit the p450 system (",
"    <a class=\"graphic graphic_table graphicRef82330 \" href=\"mobipreview.htm?34/38/35435\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/9\">",
"     9",
"    </a>",
"    ]. Cytochrome p450 genetic polymorphism appears to predispose some individuals to phenytoin toxicity secondary to slow metabolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/51/14138?source=see_link\">",
"     Fosphenytoin",
"    </a>",
"    is a prodrug that is converted to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    by serum and tissue alkaline phosphatases. Fosphenytoin is more expensive than phenytoin and is only available for intravenous and intramuscular administration. The fosphenytoin preparation does not contain propylene glycol and was initially thought to provide a safer means for rapid intravenous infusion, although cardiac toxicity and deaths from fosphenytoin have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/3,15\">",
"     3,15",
"    </a>",
"    ]. Literature review demonstrates a very similar adverse effect profile to phenytoin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/51/14138?source=see_link\">",
"     Fosphenytoin",
"    </a>",
"    binds to serum proteins and, in the presence of renal or hepatic disease, its plasma concentration will be elevated and its rate of conversion to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    may accelerate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.) Additionally, fosphenytoin will competitively displace phenytoin from plasma protein binding sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     History and drug administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    toxicity (from overdoses or chronic toxicity) is frequently encountered in patients with epilepsy, particularly after a change in medication dosing. Such patients generally complain of worsening coordination. More serious intoxication is usually seen with intentional ingestions or therapeutic error. Intravenous loading of phenytoin in a patient presumed to be noncompliant is a common scenario. To avoid the latter error, we recommend obtaining a serum phenytoin concentration prior to IV loading to treat assumed noncompliance. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Management'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Rapid administration of parenteral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and, to a possibly lesser extent,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/51/14138?source=see_link\">",
"     fosphenytoin",
"    </a>",
"    , is associated with hypotension, bradyarrhythmias, and occasional asystole [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/3,18\">",
"     3,18",
"    </a>",
"    ]. These manifestations are avoided by slow (less than 50",
"    <span class=\"nowrap\">",
"     mg/min)",
"    </span>",
"    intravenous administration.",
"   </p>",
"   <p>",
"    In cases of overdose with oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , the clinician should inquire about depression, intentional self-injury, coingestants, and use of illicit drugs. Additional history regarding trauma, past medical history, and current medications may help to identify comorbidities and coingestants. General issues related to the history and physical examination of the poisoned patient are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=see_link\">",
"     \"General approach to drug poisoning in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The earliest signs of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    toxicity are typically horizontal nystagmus and unsteady gait. More severe toxicity results in slurred speech, along with a gradually worsening mental status typified by lethargy, confusion, or coma. Hyperreflexia is occasionally seen.",
"   </p>",
"   <p>",
"    It is difficult to demonstrate a clear correlation between serum drug concentrations and clinical findings, and there is large individual variability. A table outlining approximate correlations is provided (",
"    <a class=\"graphic graphic_table graphicRef61755 \" href=\"mobipreview.htm?7/61/8155\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Although oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    has only rarely been reported to cause cardiac complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/6\">",
"     6",
"    </a>",
"    ], intravenous infusions of phenytoin or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/51/14138?source=see_link\">",
"     fosphenytoin",
"    </a>",
"    can cause hypotension and bradyarrhythmias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/3,18\">",
"     3,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Drug-induced hypersensitivity syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticonvulsant hypersensitivity syndrome (AHS) is a rare but serious event associated with aromatic antiepileptics, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    . AHS represents an idiosyncratic drug reaction that occurs in 1 in 1000 to 1 in 10,000 patients treated with phenytoin and has a fatality rate of 10 percent. Symptoms vary but classically include fever, rash, lymphadenopathy, and possibly other organ involvement. Pharyngitis is common. When severe, the syndrome can include hepatitis, megaloblastic anemia, rhabdomyolysis, and arteritis. AHS is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=see_link&amp;anchor=H10#H10\">",
"     \"Drug eruptions\", section on 'Hypersensitivity syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Signs of AHS are usually seen within two months of starting",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    therapy. The diagnosis is frequently missed, and must be considered in any patient on phenytoin with suggestive symptoms. Patients who develop the hypersensitivity syndrome are at risk for recurrence and may exhibit similar reactions to other anticonvulsants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Skin and soft tissue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    experience an estimated 1 in 1000 to 1 in 10,000 risk of developing toxic epidermal necrolysis or Stevens-Johnson syndrome. Development of these conditions following phenytoin exposure is idiosyncratic. Most cases occur within the first two months of phenytoin use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Skin irritation and necrosis (so-called purple glove syndrome) can occur with extravasation of IV",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    , possibly requiring surgical intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/18,20,21\">",
"     18,20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toxic levels of other anticonvulsant agents, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , may present with ataxia and altered mental status. Patients who are postictal may present with an abnormal neurological examination and depressed mental status, although isolated nystagmus and ataxia are unusual. Hypoglycemia should always be considered and ruled out in the setting of altered mental status or new-onset neurological abnormality. Ataxia may be encountered with a broad range of neurological disease and drug toxicities including: cerebellar disease (eg, stroke, hemorrhage, mass), Wernicke's Encephalopathy, ethanol or toxic alcohol overdose, and Parkinson disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/62/10217?source=see_link\">",
"     \"Wernicke's encephalopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/13/20694?source=see_link\">",
"     \"Ethanol intoxication in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/13/14554?source=see_link\">",
"     \"Clinical manifestations of Parkinson disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis of altered mental status and coma is vast and cannot be fully addressed here, but the emergency clinician should consider alternative infectious, metabolic, vascular, neurologic, toxicological, structural, and traumatic etiologies (",
"    <a class=\"graphic graphic_table graphicRef59893 \" href=\"mobipreview.htm?3/43/3773\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef70449 \" href=\"mobipreview.htm?1/11/1214\">",
"     table 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/9/28825?source=see_link\">",
"     \"Stupor and coma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/32/34311?source=see_link\">",
"     \"Evaluation of abnormal behavior in the emergency department\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=see_link\">",
"     \"Diagnosis of delirium and confusional states\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/1/36889?source=see_link\">",
"     \"Acute toxic-metabolic encephalopathy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Specific testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most emergency departments in developed nations can perform total serum",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    concentrations, which often correlate with patient examination findings. Discordant exam findings and serum concentrations should prompt consideration of alternative diagnoses. As an example, the presence of coma is generally not consistent with a serum phenytoin concentration below 30",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    (30",
"    <span class=\"nowrap\">",
"     microg/mL",
"    </span>",
"    or 120",
"    <span class=\"nowrap\">",
"     &micro;mol/L).",
"    </span>",
"    In the setting of an acute overdose, however, serum concentrations may be rising rapidly enough to account for progression to coma. Serial measurements of the serum phenytoin concentration should be obtained when patients with an acute overdose deteriorate rapidly.",
"   </p>",
"   <p>",
"    A serum albumin concentration may help explain any discordance between serum",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    concentration and clinical symptoms. Hypoalbuminemia results in a higher free phenytoin concentration at any given total phenytoin level. Because it is the free phenytoin concentration that determines toxicity but the total phenytoin concentration that is reported, hypoalbuminemic patients with a therapeutic or mildly elevated phenytoin concentration may exhibit significant toxicity. The free phenytoin concentration is generally not measured, unless the diagnosis remains in doubt following a careful clinical and laboratory evaluation.",
"   </p>",
"   <p>",
"    Further laboratory testing may include liver function tests and serum electrolytes. Hepatic dysfunction will increase the risk of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    toxicity and prolong the effects of intoxication by reducing the rate of metabolism.",
"   </p>",
"   <p>",
"    A complete blood count (CBC) rarely affects management. Remember that leukocytosis is commonly encountered after seizures, and a normal white blood cell count does not exclude meningitis or encephalitis. Computed tomography of the brain may be needed to screen for suspected intracranial pathology in patients with stupor or coma.",
"   </p>",
"   <p>",
"    In patients with anticonvulsant hypersensitivity syndrome, liver function tests will often show elevated aminotransferases and the CBC with differential will frequently show eosinophilia or marked leukocytosis. Creatine phosphokinase may be elevated if myositis is present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An electrocardiogram (ECG) reveals the arrhythmias, atrioventricular block, or sinus arrest with junctional or ventricular escape that may occur after intravenous (or very rarely oral) exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/3,6\">",
"     3,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     General testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory evaluation of the poisoned patient should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fingerstick glucose, to rule out hypoglycemia as the cause of any alteration in mental status",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       Acetaminophen",
"      </a>",
"      and salicylate concentrations, to rule out these common coingestions",
"     </li>",
"     <li>",
"      Electrocardiogram (ECG), to rule out conduction system poisoning by drugs that effect the QRS or QTc intervals",
"     </li>",
"     <li>",
"      Pregnancy test in women of childbearing age",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    toxicity is frequently encountered in general emergency practice, and most cases are readily managed with supportive care. Fatalities are rare. Protect the patient from falls secondary to ataxia. Treat nausea and vomiting with antiemetics, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    . A summary table to facilitate emergent management is provided (",
"    <a class=\"graphic graphic_table graphicRef56499 \" href=\"mobipreview.htm?37/18/38188\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Airway and breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who require endotracheal intubation, standard rapid sequence intubation (RSI) protocols can be used. Most medications used in RSI are safe in patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    intoxication, with the exception of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    , which shares phenytoin's antidysrhythmic properties (Vaughan Williams Class IB) and should not be used. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Cardiovascular",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic bradydysrhythmias following intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    administration are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/3\">",
"     3",
"    </a>",
"    ]. Most resolve soon after stopping the infusion, but some may require transcutaneous or transvenous pacing. Hypotension can be treated with IV boluses of isotonic saline. If dysrhythmias persist, alternative etiologies should be considered and cardiology consultation obtained.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"     Atropine",
"    </a>",
"    , epinephrine, and dopamine remain first line medical treatment for symptomatic bradydysrhythmias. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13850?source=see_link\">",
"     \"Advanced cardiac life support (ACLS) in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Decontamination and removal",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/52/39750?source=see_link\">",
"     Activated charcoal",
"    </a>",
"    (AC) may be useful in the setting of a recent ingestion (ie, within several hours). Multiple doses may remove some unbound",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    undergoing enterohepatic circulation, even if the phenytoin was administered intravenously [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/23\">",
"     23",
"    </a>",
"    ]. When considering treatment with AC, clinicians must weigh the potential benefits of treatment with the risks of charcoal aspiration, particularly because nausea, vomiting, and central nervous system depression occur frequently with phenytoin intoxication.",
"   </p>",
"   <p>",
"    We suggest that a single dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/52/39750?source=see_link\">",
"     activated charcoal",
"    </a>",
"    be administered to patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    overdose, unless they manifest a depressed mental status. We do not routinely use multiple doses of activated charcoal. Charcoal should be withheld in patients who cannot protect their airway, unless endotracheal intubation is performed first. However, endotracheal intubation should not be performed solely for the purpose of giving charcoal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/58/16297?source=see_link\">",
"     \"Gastrointestinal decontamination of poisoned adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gastric lavage and whole bowel irrigation are not recommended in patients with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    toxicity.",
"   </p>",
"   <p>",
"    Extracorporeal removal of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    via hemodialysis or hemofiltration is generally unnecessary, but a combination of hemodialysis and charcoal hemoperfusion was reported to successfully lower plasma phenytoin concentrations in one case of severe toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seizures from",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    toxicity have been reported, but may stem from a patient's preexisting seizure disorder. Seizures should be treated with benzodiazepines and barbiturates as needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Antidotal therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no specific treatment or antidote for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    toxicity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Hypersensitivity and skin reactions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of the anticonvulsant hypersensitivity syndrome is supportive and includes immediate discontinuation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and any other potentially inciting medications (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    ). Consultation with a rheumatologist or dermatologist is advised. Glucocorticoids are often used and may be helpful, but conclusive evidence of their efficacy is lacking. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=see_link\">",
"     \"Drug eruptions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients who develop toxic epidermal necrolysis or Stevens-Johnson syndrome receive standard treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Monitoring and disposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with acute",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    overdose who are symptomatic should be admitted to the hospital. Serial phenytoin concentrations should be obtained roughly every two hours until the serum concentration has stabilized, as it can increase over the first several hours, especially if gastrointestinal decontamination is inadequate. Falling serum concentrations correlate with clinical improvement, generally noted by the resolution of ataxia, slurred speech, and nystagmus. Once medical symptoms resolve, psychiatric consultation is needed for all cases of intentional ingestion.",
"   </p>",
"   <p>",
"    The disposition of the patient with chronic",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    toxicity depends on both the degree of toxicity and social circumstances. As a general rule, patients may be discharged home if they can ambulate safely and have someone (eg, family member, partner) who will stay with them and assist with the activities of daily living until toxicity has completely resolved. Patients who cannot ambulate safely or do not have someone to provide assistance should be admitted to the hospital.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PEDIATRIC CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should maintain a lower threshold to admit children with suspected",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    toxicity. Children may manifest clinical signs of phenytoin toxicity at serum concentrations lower than adults. Furthermore, the presentation of significant toxicity may be more subtle and examination findings limited.",
"   </p>",
"   <p>",
"    As with adults, the basis for decision-making is clinical evaluation rather than laboratory testing.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    toxicity should be considered in the differential diagnosis for any pediatric patient with nystagmus and ataxia or altered mental status, and a family member known to take anticonvulsants. Infants and toddlers cannot demonstrate ataxia and intoxication may be difficult to detect. These patients may present with indistinct signs such as lethargy, poor feeding, or hypotonia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum drug concentrations above 40",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    (40",
"    <span class=\"nowrap\">",
"     microg/mL",
"    </span>",
"    or 160",
"    <span class=\"nowrap\">",
"     &micro;mol/L),",
"    </span>",
"    however, are sufficient reason for admission and observation. Older children with less significant symptoms (eg, nystagmus and mild ataxia), responsible caretakers, and prearranged neurology follow-up may be discharged home with clear instructions to return immediately for any worsening of symptoms.",
"   </p>",
"   <p>",
"    Because many cases of lethal",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    toxicity in children are due to therapeutic error, children receiving parenteral administrations must be carefully monitored [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41863/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4023719\">",
"    <span class=\"h1\">",
"     ADDITIONAL RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    medical toxicologists available for bedside consultation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. The World Health Organization provides a listing of international poison centers at its website:",
"    <a class=\"external\" href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\">",
"     www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       Phenytoin",
"      </a>",
"      toxicity is associated with very few serious adverse events or fatalities. Signs of mild to moderate toxicity (serum concentrations below 40",
"      <span class=\"nowrap\">",
"       mg/L",
"      </span>",
"      [40",
"      <span class=\"nowrap\">",
"       microg/mL",
"      </span>",
"      or 160",
"      <span class=\"nowrap\">",
"       &micro;mol/L])",
"      </span>",
"      are typically confined to nystagmus, ataxia, slurred speech, nausea, and vomiting. At higher levels of toxicity, mental status can deteriorate to coma, and cardiac dysrhythmias and seizures may occur. A summary table to facilitate emergent management is provided (",
"      <a class=\"graphic graphic_table graphicRef56499 \" href=\"mobipreview.htm?37/18/38188\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two common iatrogenic causes of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      intoxication include intravenous (IV) loading of phenytoin in a patient presumed to be noncompliant and overly rapid IV administration. To avoid these errors, a serum phenytoin concentration should be obtained prior to IV loading, and the rate of IV phenytoin administration should be kept below 50",
"      <span class=\"nowrap\">",
"       mg/min.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H6\">",
"       'History and drug administration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Toxic levels of other anticonvulsant agents, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      , may also present with ataxia and altered mental status. The differential diagnosis for symptoms consistent with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      intoxication is broad, and includes hypoglycemia, postictal state, cerebellar disease (eg, stroke, hemorrhage, mass), Wernicke's encephalopathy, and ethanol or toxic alcohol overdose. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A serum",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      concentration should be obtained whenever poisoning with this drug is suspected. Serial levels can be helpful, particularly if the patient acutely decompensates. Serum concentrations generally correlate with clinical findings. Discordant serum concentrations and clinical signs should prompt consideration of alternative diagnoses. Standard toxicologic screening tests should be performed for any patient with an intentional or unclear overdose. Other studies are obtained based upon clinical circumstance. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      intoxication consists of supportive care. The airway, breathing, and circulation of the rare unstable patient are stabilized as necessary. In patients with phenytoin overdose but without a depressed mental status, we suggest administering a single dose of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/52/39750?source=see_link\">",
"       activated charcoal",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We do not routinely use multiple doses of activated charcoal. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who are symptomatic from an acute",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      overdose should be admitted to the hospital. Patients with chronic phenytoin toxicity may generally be discharged home if they can ambulate safely and have someone who will stay with them and assist with the activities of daily living until toxicity has completely resolved. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Monitoring and disposition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children may manifest clinical signs of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      toxicity at serum concentrations lower than adults, so a more liberal threshold for admission and monitoring is used. As with adults, the basis for decision-making is clinical evaluation rather than laboratory testing. Infants and toddlers may present with indistinct signs such as lethargy, poor feeding, or hypotonia. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Pediatric considerations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/1\">",
"      Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila) 2009; 47:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/2\">",
"      Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/3\">",
"      Adams BD, Buckley NH, Kim JY, Tipps LB. Fosphenytoin may cause hemodynamically unstable bradydysrhythmias. J Emerg Med 2006; 30:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/4\">",
"      Chua HC, Venketasubramanian N, Tan CB, Tjia H. Paradoxical seizures in phenytoin toxicity. Singapore Med J 1999; 40:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/5\">",
"      Osorio I, Burnstine TH, Remler B, et al. Phenytoin-induced seizures: a paradoxical effect at toxic concentrations in epileptic patients. Epilepsia 1989; 30:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/6\">",
"      Su CM, Kung CT, Wang YC, Lu CH. Life-threatening cardiotoxicity due to chronic oral phenytoin overdose. Neurol India 2009; 57:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/7\">",
"      Mixter CG 3rd, Moran JM, Austen WG. Cardiac and peripheral vascular effects of diphenylhydantoin sodium. Am J Cardiol 1966; 17:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/8\">",
"      Gugler R, Manion CV, Azarnoff DL. Phenytoin: pharmacokinetics and bioavailability. Clin Pharmacol Ther 1976; 19:135.",
"     </a>",
"    </li>",
"    <li>",
"     Phenytoin. International programme on chemical safety, poisons information monograph 416. file://www.inchem.org/ (Accessed on October 05, 2006).",
"    </li>",
"    <li>",
"     Phenytoin Sodium. Hazardous Substance Data Bank 3160, Revision 2005. file://toxnet.nlm.nih.gov (Accessed on October 05, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/11\">",
"      Giancarlo GM, Venkatakrishnan K, Granda BW, et al. Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine. Eur J Clin Pharmacol 2001; 57:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/12\">",
"      Holcomb R, Lynn R, Harvey B Jr, et al. Intoxication with 5,5-diphenylhydantoin (Dilantin): clinical features, blood levels, urinary metabolites, and metabolic changes in a child. J Pediatr 1972; 80:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/13\">",
"      Anderson GD. Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 2004; 63:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/14\">",
"      McCluggage LK, Voils SA, Bullock MR. Phenytoin toxicity due to genetic polymorphism. Neurocrit Care 2009; 10:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/15\">",
"      Browne TR, Kugler AR, Eldon MA. Pharmacology and pharmacokinetics of fosphenytoin. Neurology 1996; 46:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/16\">",
"      Eriksson K, Ker&auml;nen T, K&auml;lvi&auml;inen R. Fosphenytoin. Expert Opin Drug Metab Toxicol 2009; 5:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/17\">",
"      Aweeka FT, Gottwald MD, Gambertoglio JG, et al. Pharmacokinetics of fosphenytoin in patients with hepatic or renal disease. Epilepsia 1999; 40:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/18\">",
"      Earnest MP, Marx JA, Drury LR. Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage. JAMA 1983; 249:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/19\">",
"      Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 2005; 64:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/20\">",
"      Comer, JB. Extravasation from intravenous phenytoin. Intrav Ther Clin Nutr 1984; 11:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/21\">",
"      Kilarski DJ, Buchanan C, Von Behren L. Soft-tissue damage associated with intravenous phenytoin. N Engl J Med 1984; 311:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/22\">",
"      Engel JN, Mellul VG, Goodman DB. Phenytoin hypersensitivity: a case of severe acute rhabdomyolysis. Am J Med 1986; 81:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/23\">",
"      Mauro LS, Mauro VF, Brown DL, Somani P. Enhancement of phenytoin elimination by multiple-dose activated charcoal. Ann Emerg Med 1987; 16:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41863/abstract/24\">",
"      Eyer F, Felgenhauer N, Pfab R, et al. Treatment of severe intravenous phenytoin overdose with hemodialysis and hemoperfusion. Med Sci Monit 2008; 14:CS145.",
"     </a>",
"    </li>",
"    <li>",
"     Barrueto, F, Jr, Nelson, LS. Antiepileptic Agents. In: Pediatric Toxicology: Diagnosis &amp; Management of the Poisoned Child, Erickson, TB, Ahrens, WR, Aks, SE, et al (Eds), McGraw-Hill, New York 205. p.283.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 312 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-217.117.136.88-353D9881C8-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41863=[""].join("\n");
var outline_f40_56_41863=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PHARMACOLOGY AND CELLULAR TOXICOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PHARMACOKINETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      History and drug administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Drug-induced hypersensitivity syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Skin and soft tissue",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Specific testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      General testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Airway and breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Cardiovascular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Decontamination and removal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Antidotal therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Hypersensitivity and skin reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Monitoring and disposition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PEDIATRIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4023719\">",
"      ADDITIONAL RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/312\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/312|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/18/38188\" title=\"table 1\">",
"      Phenytoin poisoning - Rapid overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/38/35435\" title=\"table 2\">",
"      Drugs that alter phenytoin concentrations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/61/8155\" title=\"table 3\">",
"      Phenytoin concentrations and clinical signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/43/3773\" title=\"table 4\">",
"      Causes of delirium and confusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/11/1214\" title=\"table 5\">",
"      Drugs that cause or prolong delirium",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/1/36889?source=related_link\">",
"      Acute toxic-metabolic encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13850?source=related_link\">",
"      Advanced cardiac life support (ACLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/13/14554?source=related_link\">",
"      Clinical manifestations of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=related_link\">",
"      Diagnosis of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=related_link\">",
"      Drug eruptions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/13/20694?source=related_link\">",
"      Ethanol intoxication in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/32/34311?source=related_link\">",
"      Evaluation of abnormal behavior in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/58/16297?source=related_link\">",
"      Gastrointestinal decontamination of poisoned adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/6/1129?source=related_link\">",
"      General approach to drug poisoning in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40570?source=related_link\">",
"      Overview of the management of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/9/28825?source=related_link\">",
"      Stupor and coma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/62/10217?source=related_link\">",
"      Wernicke's encephalopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_56_41864="Comprehensive geriatric assessment for patients with cancer";
var content_f40_56_41864=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Comprehensive geriatric assessment for patients with cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41864/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41864/contributors\">",
"     Arti Hurria, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41864/contributors\">",
"     Harvey Jay Cohen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41864/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41864/contributors\">",
"     Reed E Drews, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41864/contributors\">",
"     Kenneth E Schmader, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41864/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41864/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/56/41864/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 60 percent of new cases and 70 percent of mortality from cancer occur in patients &ge;65 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/1\">",
"     1",
"    </a>",
"    ]. As a result, the care of older patients constitutes an important part of the everyday practice for the adult oncologist.",
"   </p>",
"   <p>",
"    Despite the high incidence of cancer in this group, older patients have been underrepresented in clinical trials that set the standards for care in oncology practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Less data exist regarding the risks and benefits of cancer treatment in this population, and there are few guidelines that specifically address the evaluation and treatment of the older patient.",
"   </p>",
"   <p>",
"    Older patients are less likely to receive all types of standard cancer therapies compared to younger individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/5-12\">",
"     5-12",
"    </a>",
"    ]. Possible reasons include concerns regarding increased toxicity, competing causes of morbidity and mortality, lack of access to care, and physician or patient preference.",
"   </p>",
"   <p>",
"    Chronologic age alone provides relatively little information regarding an individual's tolerance to cancer treatment. Among patients of the same age, there is wide heterogeneity in the ability to undergo aggressive therapy.",
"   </p>",
"   <p>",
"    Identifiable comorbid conditions and organ-specific physiologic changes due to aging can limit a patient's ability to tolerate cancer therapy. In addition, the aging process can be associated with decreased physiologic reserve affecting multiple systems. This can be manifested as frailty and can interfere with the functional status of the patient, even in the absence of specific comorbidities. The manifestations of frailty include various components of weight loss, exhaustion, weakness, relative immobility, and a general decrease in physical activity.",
"   </p>",
"   <p>",
"    There is a need to identify the seemingly frail older individual who is likely to benefit from and tolerate standard therapy, as well as the seemingly fit older individual who is apt to experience undue side effects and requires a modified treatment plan. The evaluation of frailty in elderly adults (clinical and potential physiologic predictors) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/26/34215?source=see_link&amp;anchor=H3#H3\">",
"     \"Failure to thrive in elderly adults: Evaluation\", section on 'Frailty'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Information about specific issues may guide interventions that can improve the ability to undergo cancer treatment. A comprehensive geriatric assessment (CGA) looking at all of the factors that can influence the outcome to therapy is useful in addressing these needs.",
"   </p>",
"   <p>",
"    The key components of a CGA as applied to patients with cancer will be reviewed here, along with the different approaches for obtaining this information. A more detailed discussion of the CGA, general aspects of the treatment of cancer in the elderly patients, and the management of elderly patients with specific types of cancer are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/38/43624?source=see_link\">",
"     \"Comprehensive geriatric assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/42/10922?source=see_link\">",
"     \"Systemic chemotherapy for cancer in elderly persons\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     POTENTIAL BENEFITS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A CGA is a standard part of a geriatrician's baseline evaluation of an older individual.",
"   </p>",
"   <p>",
"    Several studies have suggested a wide range of possible benefits from using a CGA in patients with cancer. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Predicting complications and side effects from treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/13-15\">",
"       13-15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Estimating survival [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/16\">",
"       16",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Assisting in cancer treatment decisions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/17,18\">",
"       17,18",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Detecting problems not found by routine history and physical examination in the initial evaluation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/19-22\">",
"       19-22",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Identifying and treating of new problems during the follow-up care [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/21,23\">",
"       21,23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Improving mental health and well being [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Better pain control [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4976081\">",
"    <span class=\"h2\">",
"     Who needs a CGA?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consensus guidelines from both the National Comprehensive Cancer Network (NCCN) and the International Society for Geriatric Oncology recommend the routine use of a geriatric assessment for the older patient with cancer (defined as age 65 or older) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. However, although a CGA is helpful for physicians to develop a coordinated plan for cancer treatment and to guide appropriate interventions for specific problems, it can be time consuming and may not be practical for all patients. Some have suggested the use of a screening tool (assessment of autonomy, malnutrition, depression, cognition, and comorbidity) to identify vulnerable patients for whom a CGA could potentially optimize their cancer treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/27\">",
"     27",
"    </a>",
"    ]. In our practice, we utilize a CGA in every patient age 65 and older, using a self-administered CGA assessment tool, as described in more detail below (",
"    <a class=\"graphic graphic_table graphicRef70657 \" href=\"mobipreview.htm?2/27/2492\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Self-administered CGA'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DOMAINS OF A CGA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical domains of a CGA include evaluations of functional status, comorbid medical conditions, cognitive status, psychological state, social support, nutritional status, and a review of the medication list.",
"   </p>",
"   <p>",
"    Impaired functional status and significant comorbidity can have significant effects on the ability to administer systemic chemotherapy in the elderly patient. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/42/10922?source=see_link\">",
"     \"Systemic chemotherapy for cancer in elderly persons\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Functional status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional status refers to a patient's ability to perform routine daily tasks. The commonly used performance status scores (eg, Karnofsky or Eastern Cooperative Oncology Group (ECOG) scales (",
"    <a class=\"graphic graphic_table graphicRef58785 \" href=\"mobipreview.htm?2/11/2236\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef72901 \" href=\"mobipreview.htm?9/15/9467\">",
"     table 3",
"    </a>",
"    )) tend to underrepresent the degree of functional impairment in the older patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A more comprehensive understanding of an older patient's functional state can be obtained by the Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) scales. ADLs are the skills that are necessary for basic living, and include feeding, grooming, transferring, and toileting. IADLs are required to live independently in the community and include activities such as shopping, managing finances, housekeeping, preparing meals, and taking medications. In a study of 363 cancer patients aged &ge;65 years, an ECOG performance status &lt;2 (",
"    <a class=\"graphic graphic_table graphicRef72901 \" href=\"mobipreview.htm?9/15/9467\">",
"     table 3",
"    </a>",
"    ) was associated with limitations of ADL and IADL in 9 and 38 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/20\">",
"     20",
"    </a>",
"    ]. The frequency of IADL limitations was more common in patients aged &ge;80 years.",
"   </p>",
"   <p>",
"    Functional disability is common in older patients with cancer. This was illustrated by a national sample of 9745 community-based Medicare beneficiaries, in which older adults with cancer had more limitations in ADLs, IADLs, and greater health care utilization than individuals without cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar results were seen in another study of 303 patients aged &ge;65 years with solid tumors or hematologic malignancies, in which limitations in ADLs and IADLs were found in 17 and 59 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/44/43719?source=see_link\">",
"     \"Functional problems in the patient with cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The impact of functional status on the overall survival of older patients with cancer was illustrated by a study of 566 patients with advanced non&ndash;small cell lung cancer age &ge;70 years receiving chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/16\">",
"     16",
"    </a>",
"    ]. In this study, improved overall survival was associated with independence in performing IADLs (p=0.04) and higher quality of life (p=0.0003) scores. Limitations in basic ADLs and the presence of comorbidity were not predictors of a decrease in overall survival.",
"   </p>",
"   <p>",
"    Impaired functional status is associated with an increased risk of toxicity due to chemotherapy. This was demonstrated in two multicenter studies that identified predictors of chemotherapy toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. In both of these studies, the patient&rsquo;s functional status was a key predictor.",
"   </p>",
"   <p>",
"    In the study by the Cancer and Aging Research Group, the functional measures that predicted chemotherapy toxicity risk included falls in the last six months, limitations in walking one block, need for assistance with taking medications, and decreased social activities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/15\">",
"     15",
"    </a>",
"    ]. The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score identified the need for assistance with instrumental activities of daily living as a predictor of chemotherapy toxicity. Another study of patients aged &ge;70 years with ovarian cancer who were receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    identified functional dependence (defined as living at home with assistance or living with medical assistance in a specialized institution) and ECOG performance status &ge;2 as predictors of chemotherapy toxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Comorbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comorbidity represents the extent of an individual's physical and psychological disease in addition to the disease for which he or she is seeking treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/31\">",
"     31",
"    </a>",
"    ]. As an individual ages, the number of comorbid medical conditions increases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/32\">",
"     32",
"    </a>",
"    ]. The impact of these comorbid medical conditions on life expectancy and treatment tolerance should be considered when estimating the risks and benefits of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The importance of comorbidity is illustrated by analyses from three large series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A longitudinal observational study of 936 women with breast cancer ages 40 to 84 found that patients who had three or more comorbid medical conditions had a 20-fold higher rate of mortality from causes other than breast cancer and a four-fold higher all-cause mortality rate compared to those who had no comorbid medical conditions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A second report analyzed 1255 patients with non-small cell lung cancer who were enrolled in two randomized trials conducted by the National Cancer Institute of Canada [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/35\">",
"       35",
"      </a>",
"      ]. Patients at least 65 years of age were significantly more likely to have a Charlson Comorbidity Index score &ge;1 than younger patients (42 versus 26 percent) (",
"      <a class=\"graphic graphic_table graphicRef72047 \" href=\"mobipreview.htm?25/40/26252\">",
"       table 4",
"      </a>",
"      ). Although age was not an independent factor influencing survival, comorbidity, as evidenced by a Charlson Comorbidity Index score &ge;1, was associated with increased mortality (hazard ratio [HR] 1.28, 95% CI 1.09-1.50).",
"     </li>",
"     <li>",
"      A third study analyzed the impact of comorbidity using three different instruments in a series of 496 patients (mean age 67 years) undergoing surgery for colorectal cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/36\">",
"       36",
"      </a>",
"      ]. Analysis using the Charlson Comorbidity Index, the National Institute on Aging and National Cancer Institute Comorbidity Index, and the Adult Comorbidity Evaluation-27 all found that patients with the highest comorbidity burden had the poorest overall and colon cancer-specific survival.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to its effect on survival, the presence of comorbid medical conditions also affects a patient's ability to tolerate cancer therapy. In a study of patients aged &ge;70 years with advanced non&ndash;small cell lung cancer, for example, those with a Charlson Comorbidity Index of &ge;2 were more likely to discontinue chemotherapy early than patients with a comorbidity score &lt;2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An assessment of comorbid medical conditions can provide information that is independent of the individual's functional status. This was illustrated by a study of 203 older patients with cancer, in whom there was little or no correlation between comorbidity (as measured by either the Charlson Comorbidity Index or Cumulative Illness Rating Scale &ndash; Geriatric) and functional status (as assessed by ECOG performance status or ADLs). Thus it is important to assess comorbidity as well as functional status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cognitive function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive function is another important component of the overall assessment of the geriatric patient with cancer. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=see_link\">",
"     \"Evaluation of cognitive impairment and dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the general geriatric population, dementia is an independent prognostic factor for survival. The presence of dementia influences the likelihood of both cancer diagnosis and treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/39\">",
"     39",
"    </a>",
"    ]. In a population cohort study using the Surveillance, Epidemiology and End Results (SEER) Medicare database, patients with invasive colon cancer and dementia were more likely to have a cancer diagnosis reported after death based upon either an autopsy or death certificate, than patients who did not have dementia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/40\">",
"     40",
"    </a>",
"    ]. In addition, patients with dementia were less likely to have a biopsy-proven diagnosis of cancer and were less likely to receive surgery or chemotherapy. In another study using the SEER database, patients with Alzheimer disease and breast cancer were more likely to be diagnosed with a later stage of breast cancer and were less likely to receive treatment for their malignancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    From a practical standpoint, an assessment of cognitive status is important prior to beginning chemotherapy treatment in order to ensure that the patient can comply with instructions regarding supportive medications or oral chemotherapy, and in order to understand and remember to seek medical attention if side effects develop.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutritional status is an important prognostic factor in all geriatric patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23175?source=see_link\">",
"     \"Dietary and nutritional assessment in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the general older population, there are several reports demonstrating the adverse impact of weight loss or low body mass index (BMI) even when subjects do not have cancer (",
"    <a class=\"graphic graphic_figure graphicRef65305 \" href=\"mobipreview.htm?12/3/12351\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/42-46\">",
"     42-46",
"    </a>",
"    ]. The importance of weight loss was illustrated by a study of 4714 community-dwelling adults age &ge;65 years, in which weight loss &ge;5 percent was associated with an increased risk of mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/42\">",
"     42",
"    </a>",
"    ]. Similar results were seen in another study of 7527 individuals age &ge;70 years, in which a BMI &lt;19.4",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    (the lowest 10 percent of the population) was associated with an increased risk of mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among patients with cancer, the deleterious effect of weight loss on survival was demonstrated in a study of 3047 patients enrolled in 12 ECOG chemotherapy protocols [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/47\">",
"     47",
"    </a>",
"    ]. In this analysis, weight loss was an independent prognostic factor for survival and was associated with a lower performance status. Furthermore, weight loss was associated with a decrease in chemotherapy response rates in women with breast cancer, although this correlation was not present in other tumor types. Even a limited weight loss (0 to 5 percent) can be clinically significant in patients with cancer.",
"   </p>",
"   <p>",
"    Thus, the adverse effects of weight loss and low BMI have been demonstrated in all older patients including those with cancer. Future studies are needed to determine whether nutritional intervention can decrease these risks. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/34/17960?source=see_link\">",
"     \"Clinical features and pathogenesis of cancer cachexia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/63/5113?source=see_link\">",
"     \"Pharmacologic management of cancer anorexia/cachexia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Psychological state and social support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the incidence and severity of psychological distress are reported to be less than that observed in younger patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/48,49\">",
"     48,49",
"    </a>",
"    ], approximately one-third of older patients with cancer experience psychological distress. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/22/31080?source=see_link\">",
"     \"Diagnosis of psychiatric and psychologic disorders in patients with cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This most typically takes the form of depression. The prevalence of clinically significant depression is estimated to be 3 to 25 percent in the older population with cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/48\">",
"     48",
"    </a>",
"    ]. The consequences of depression in this group include an increased risk of subsequent functional decline and with increased utilization of healthcare resources [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/50\">",
"     50",
"    </a>",
"    ]. This was illustrated in a survey of 6649 patients aged &gt;70 years, in which the presence of increasing numbers of depressive symptoms was associated with a need for more hours of informal caregiving [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The patients who are most vulnerable to psychological distress are those with inadequate social support. This was illustrated by a study of breast cancer survivors, in which older age was associated with less distress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/52\">",
"     52",
"    </a>",
"    ]. However, patients with less adequate social support experienced increased distress. In addition, social isolation is also an independent predictor of mortality in the geriatric population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Medication review",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful review of medications is an important component of the CGA. Physiological changes associated with aging can have a major impact on drug pharmacokinetics and pharmacodynamics. With aging, body fat increases, total body water and renal function decrease, and hepatic mass and blood flow decrease. In addition, the number of medications that an individual takes also increases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/0/30730?source=see_link\">",
"     \"Drug prescribing for older adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This combination of age-related changes in physiology and polypharmacy is associated with an increased risk of adverse drug events in the older patient. Therefore, a regular review of the medication list is needed to remove any unnecessary medications and to assess for potential drug interactions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/54-56\">",
"     54-56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     OBTAINING PATIENT DATA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although consensus guidelines recommend that older patients with cancer undergo a CGA, there is no consensus regarding an optimal tool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. The various approaches that have been studied recognize the limited resources available in an oncology practice, and several different methods of obtaining this information have been explored. These screening tools can potentially identify older adults who would benefit from a more thorough evaluation or collaborative care with a geriatrician. Here we will briefly review several assessment methods.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Mailed CGA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A self-reported, mailed CGA was evaluated in a population of male oncology patients (mean age 68, range 42 to 87) at the Durham, North Carolina, Veterans Administration Medical Center [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/57\">",
"     57",
"    </a>",
"    ]. The assessment evaluated functional status, pain, financial well being, social support, psychological state, spiritual well being, and quality of life (",
"    <a class=\"graphic graphic_table graphicRef60695 \" href=\"mobipreview.htm?28/8/28811\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The CGA was sent to participants prior to their initial clinic visit, and 76 percent of patients kept their clinic visit and returned the assessment. The mailed CGA was effective in capturing salient information about the different assessment domains. For example, 58 percent of patients required assistance with one or more IADLs, 61 percent required assistance with one or more ADLs, the mean number of comorbid medical conditions was five, and the mean number of medications was six.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Self-administered CGA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Investigators from the Cancer and Leukemia Group B, Cancer in the Elderly Committee, developed a CGA that is primarily self-administered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/28\">",
"     28",
"    </a>",
"    ]. This assessment is a compilation of well-validated instruments that evaluate functional status, comorbidity, cognition, nutritional status, psychological state, social support, and medication use (",
"    <a class=\"graphic graphic_table graphicRef70657 \" href=\"mobipreview.htm?2/27/2492\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Three of the instruments are performed by the healthcare provider: the Blessed Orientation-Memory-Concentration Test (a measure of cognition), Timed Up and Go (a performance-based measure of functional status), and Karnofsky performance status (",
"    <a class=\"graphic graphic_table graphicRef58785 \" href=\"mobipreview.htm?2/11/2236\">",
"     table 2",
"    </a>",
"    ). The remainder of the assessment is self-administered by the patient.",
"   </p>",
"   <p>",
"    Pilot data demonstrate that the mean time to complete the assessment is 27 minutes, and 78 percent of participants could complete the self-administered portion on their own. Overall, 90 percent of participants were satisfied with the length of the questionnaire, 83 percent reported that it was easy to understand, and 100 percent stated that there were no upsetting items [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/28\">",
"     28",
"    </a>",
"    ]. The Cancer and Leukemia Group B, Cancer in the Elderly Committee evaluated the feasibility of including this primarily self-administered assessment in CALGB trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/15\">",
"     15",
"    </a>",
"    ]. The median time to complete the geriatric assessment tool was 22 minutes. The majority (87 percent) of patients completed the assessment without assistance. Furthermore, patient satisfaction with the questionnaire was high (92 percent reported satisfaction with the questionnaire length, 95 percent reported no difficult questions, and 96 percent reported no upsetting questions). The assessment met the feasibility criteria specified in the protocol for inclusion in future cooperative group studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Clinical interview",
"    </span>",
"    &nbsp;&mdash;&nbsp;A third approach, using a clinical interview for the CGA, was evaluated in 30 patients aged 65 and older with a variety of tumor types [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/58\">",
"     58",
"    </a>",
"    ]. The Multidimensional Assessment Protocol for Cancer (MACE) includes an evaluation of the socioeconomic status, cognitive status, depression, physical performance, disability, and tumor characteristics (",
"    <a class=\"graphic graphic_table graphicRef70602 \" href=\"mobipreview.htm?22/18/22827\">",
"     table 6",
"    </a>",
"    ). The mean time for administering the MACE was 27 minutes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Pre-CGA screening tools",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple approaches have been made to develop &ldquo;simplified CGAs&rdquo;, which are intended to be quick screening tools to determine who could benefit from a full CGA.&nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An abbreviated CGA was developed by performing a retrospective chart review of 500 patients who underwent a geriatric assessment consisting of an evaluation of functional status (ADLs and IADLs), cognition (MMSE), and psychological state (Geriatric Depression Scale). The authors identified 15 items from these scales that demonstrated the highest item to total correlation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another alternative is the Vulnerable Elders Survey-13 (VES-13) (",
"      <a class=\"graphic graphic_table graphicRef73154 \" href=\"mobipreview.htm?18/14/18668\">",
"       table 7",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/60-62\">",
"       60-62",
"      </a>",
"      ]. This approach utilizes a function-based scoring system that considers age, self-rated health, physical limitations, and functional disabilities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, all frailty screening methods, including the VES-13, have a limited power to predict outcome of a CGA. A systematic review of several frailty screening methods, including the VES-13, concluded that they all had limited specificity; furthermore, the negative predictive value of the most sensitive screening tool was only 60 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These tools are not intended to be a CGA or replace the need for one. They do not really identify issues that can be follow-up specifically to try to improve outcomes. While they have been used for prognostication and probably work almost as well as a full CGA for that, they do not substitute for a CGA for all purposes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     USE OF CGA RESULTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The information from the CGA can be used in a number of ways to assist in decision making regarding overall management of the older patient with cancer. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Some authors have classified the older population into specific groups for the purpose of selecting the treatment strategy, based upon their functional status, rehabilitative potential, life expectancy and tolerance of stress (",
"      <a class=\"graphic graphic_table graphicRef60632 \" href=\"mobipreview.htm?20/18/20779\">",
"       table 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_algorithm graphicRef67375 \" href=\"mobipreview.htm?4/10/4270\">",
"       algorithm 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/64-67\">",
"       64-67",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Others have developed a nomogram based upon domains and elements of the CGA that predicts the probability of one-, two- and three-year overall survival for elderly patients with cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The information obtained from the CGA has also been combined with other information, including the proposed chemotherapy regimen, hematologic and renal function, hearing impairment, and cancer type, to derive a model used to predict chemotherapy toxicity in the elderly (",
"      <a class=\"graphic graphic_table graphicRef78775 \" href=\"mobipreview.htm?17/51/18237\">",
"       table 9",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef60649 \" href=\"mobipreview.htm?41/40/42636\">",
"       table 10",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/15\">",
"       15",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/42/10922?source=see_link&amp;anchor=H1242770806#H1242770806\">",
"       \"Systemic chemotherapy for cancer in elderly persons\", section on 'Models predicting chemotherapy toxicity and early death'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There have been few studies that have evaluated whether routine geriatric assessment impacts outcomes or influences treatment decision making in older patients with cancer. A systematic review of 73 studies of geriatric assessment in older cancer patients reported that none of the included studies were randomized trials specifically designed to examine the effectiveness of geriatric assessment with regard to medical decision making [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41864/abstract/69\">",
"     69",
"    </a>",
"    ]. Specific domains of the geriatric assessment were associated with treatment-related toxicity in six of nine studies and with mortality in 8 of 16 studies; two of the four published studies found that geriatric assessment impacted 40 to 50 percent of treatment decisions. Randomized trials are needed to examine the effectiveness of geriatric assessment in older patients with cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancer is an important and disproportionate cause of morbidity and mortality in the geriatric population. A comprehensive geriatric assessment (CGA) can help achieve the required balance between the potential benefits and side effects of therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/38/43624?source=see_link\">",
"     \"Comprehensive geriatric assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The key domains that are included in the CGA are the functional status, comorbidity, cognition, nutrition, psychological state, social support, and medication review. Various approaches to gathering this information have been used including a mailed or self-administered assessment. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Domains of a CGA'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The information from a geriatric assessment can be used to anticipate and manage toxicity from treatment, predict survival, uncover expected health problems, improve the mental health and well being, and improve pain control. Randomized trials are needed to examine the effectiveness of geriatric assessment in older patients with cancer. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Potential benefits'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Ries EM, Kosary CL, Hankey BF, et al. SEER Cancer Statistics Review: 1975-2000. National Cancer Institute, Bethesda, MD.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/2\">",
"      Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/3\">",
"      Yee KW, Pater JL, Pho L, et al. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? J Clin Oncol 2003; 21:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/4\">",
"      Trimble EL, Carter CL, Cain D, et al. Representation of older patients in cancer treatment trials. Cancer 1994; 74:2208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/5\">",
"      Christman K, Muss HB, Case LD, Stanley V. Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment]. JAMA 1992; 268:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/6\">",
"      Hurria A, Leung D, Trainor K, et al. Factors influencing treatment patterns of breast cancer patients age 75 and older. Crit Rev Oncol Hematol 2003; 46:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/7\">",
"      Mandelblatt JS, Hadley J, Kerner JF, et al. Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer 2000; 89:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/8\">",
"      Newcomb PA, Carbone PP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst 1993; 85:1580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/9\">",
"      Merchant TE, McCormick B, Yahalom J, Borgen P. The influence of older age on breast cancer treatment decisions and outcome. Int J Radiat Oncol Biol Phys 1996; 34:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/10\">",
"      Bergman L, Dekker G, van Leeuwen FE, et al. The effect of age on treatment choice and survival in elderly breast cancer patients. Cancer 1991; 67:2227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/11\">",
"      Bergman L, Kluck HM, van Leeuwen FE, et al. The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: a population-based study. Eur J Cancer 1992; 28A:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/12\">",
"      Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001; 93:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/13\">",
"      Freyer G, Geay JF, Touzet S, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol 2005; 16:1795.",
"     </a>",
"    </li>",
"    <li>",
"     Extermann M, Boler I, Reich R, et al. The Chemotherapy Risk Assessment Scale for High-Age patients (CRASH) score: design and validation (abstract #9000). J Clin Oncol 2010; 28:15s.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/15\">",
"      Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011; 29:3457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/16\">",
"      Maione P, Perrone F, Gallo C, et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005; 23:6865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/17\">",
"      Tucci A, Ferrari S, Bottelli C, et al. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 2009; 115:4547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/18\">",
"      Cudennec T, Gendry T, Labrune S, et al. Use of a simplified geriatric evaluation in thoracic oncology. Lung Cancer 2010; 67:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/19\">",
"      Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000; 5:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/20\">",
"      Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002; 20:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/21\">",
"      Extermann M, Meyer J, McGinnis M, et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol 2004; 49:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/22\">",
"      Pope D, Ramesh H, Gennari R, et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol 2006; 15:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/23\">",
"      Chen H, Cantor A, Meyer J, et al. Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer 2003; 97:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/24\">",
"      Rao AV, Hsieh F, Feussner JR, Cohen HJ. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol A Biol Sci Med Sci 2005; 60:798.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/26\">",
"      Extermann M, Aapro M, Bernabei R, et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005; 55:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/27\">",
"      Valero S, Migeot V, Bouche G. Who needs a Comprehensive Geriatric Assessment? A French Onco-Geriatric Screening tool. J Geriatric Oncol 2011; 2:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/28\">",
"      Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 2005; 104:1998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/29\">",
"      Stafford RS, Cyr PL. The impact of cancer on the physical function of the elderly and their utilization of health care. Cancer 1997; 80:1973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/30\">",
"      Serraino D, Fratino L, Zagonel V, GIOGer Study Group (Italy). Prevalence of functional disability among elderly patients with cancer. Crit Rev Oncol Hematol 2001; 39:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/31\">",
"      Extermann M, Aapro M. Assessment of the older cancer patient. Hematol Oncol Clin North Am 2000; 14:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/32\">",
"      Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 1997; 80:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/33\">",
"      Welch HG, Albertsen PC, Nease RF, et al. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med 1996; 124:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/34\">",
"      Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/35\">",
"      Asmis TR, Ding K, Seymour L, et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 2008; 26:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/36\">",
"      Hines RB, Chatla C, Bumpers HL, et al. Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. J Clin Oncol 2009; 27:4339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/37\">",
"      Frasci G, Lorusso V, Panza N, et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000; 18:2529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/38\">",
"      Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998; 16:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/39\">",
"      Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001; 344:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/40\">",
"      Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc 2004; 52:1681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/41\">",
"      Gorin SS, Heck JE, Albert S, Hershman D. Treatment for breast cancer in patients with Alzheimer's disease. J Am Geriatr Soc 2005; 53:1897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/42\">",
"      Newman AB, Yanez D, Harris T, et al. Weight change in old age and its association with mortality. J Am Geriatr Soc 2001; 49:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/43\">",
"      Grabowski DC, Ellis JE. High body mass index does not predict mortality in older people: analysis of the Longitudinal Study of Aging. J Am Geriatr Soc 2001; 49:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/44\">",
"      Wallace JI, Schwartz RS, LaCroix AZ, et al. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc 1995; 43:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/45\">",
"      Reynolds MW, Fredman L, Langenberg P, Magaziner J. Weight, weight change, mortality in a random sample of older community-dwelling women. J Am Geriatr Soc 1999; 47:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/46\">",
"      Landi F, Onder G, Gambassi G, et al. Body mass index and mortality among hospitalized patients. Arch Intern Med 2000; 160:2641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/47\">",
"      Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/48\">",
"      Kua J. The prevalence of psychological and psychiatric sequelae of cancer in the elderly - how much do we know? Ann Acad Med Singapore 2005; 34:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/49\">",
"      Vinokur AD, Threatt BA, Vinokur-Kaplan D, Satariano WA. The process of recovery from breast cancer for younger and older patients. Changes during the first year. Cancer 1990; 65:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/50\">",
"      Penninx BW, Guralnik JM, Ferrucci L, et al. Depressive symptoms and physical decline in community-dwelling older persons. JAMA 1998; 279:1720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/51\">",
"      Langa KM, Valenstein MA, Fendrick AM, et al. Extent and cost of informal caregiving for older Americans with symptoms of depression. Am J Psychiatry 2004; 161:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/52\">",
"      Kornblith AB, Herndon JE 2nd, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 2003; 98:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/53\">",
"      Seeman TE, Berkman LF, Kohout F, et al. Intercommunity variations in the association between social ties and mortality in the elderly. A comparative analysis of three communities. Ann Epidemiol 1993; 3:325.",
"     </a>",
"    </li>",
"    <li>",
"     Avorn J, Gurwitz JH. Geriatric Medicine, Springer-Verlag, 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/55\">",
"      Lichtman SM, Villani G. Chemotherapy in the elderly: pharmacologic considerations. Cancer Control 2000; 7:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/56\">",
"      Vestal RE. Aging and pharmacology. Cancer 1997; 80:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/57\">",
"      Ingram SS, Seo PH, Martell RE, et al. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol 2002; 20:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/58\">",
"      Monfardini S, Ferrucci L, Fratino L, et al. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer 1996; 77:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/59\">",
"      Overcash JA, Beckstead J, Extermann M, Cobb S. The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol 2005; 54:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/60\">",
"      Min LC, Elliott MN, Wenger NS, Saliba D. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc 2006; 54:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/61\">",
"      Mohile SG, Bylow K, Dale W, et al. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 2007; 109:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/62\">",
"      Luciani A, Ascione G, Bertuzzi C, et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol 2010; 28:2046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/63\">",
"      Hamaker ME, Jonker JM, de Rooij SE, et al. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 2012; 13:e437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/64\">",
"      Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999; 130:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/65\">",
"      Caillet P, Canoui-Poitrine F, Vouriot J, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 2011; 29:3636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/66\">",
"      Olivieri A, Gini G, Bocci C, et al. Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA. Oncologist 2012; 17:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/67\">",
"      Spina M, Balzarotti M, Uziel L, et al. Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist 2012; 17:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/68\">",
"      Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 2011; 29:3620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41864/abstract/69\">",
"      Puts MT, Hardt J, Monette J, et al. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 2012; 104:1133.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2808 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-180.241.123.62-6A9128D992-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41864=[""].join("\n");
var outline_f40_56_41864=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      POTENTIAL BENEFITS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4976081\">",
"      Who needs a CGA?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DOMAINS OF A CGA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Functional status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Comorbidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cognitive function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Nutrition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Psychological state and social support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Medication review",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      OBTAINING PATIENT DATA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Mailed CGA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Self-administered CGA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Clinical interview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Pre-CGA screening tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      USE OF CGA RESULTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2808\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2808|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?4/10/4270\" title=\"algorithm 1\">",
"      CGA groups BC Rx recommend",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2808|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/3/12351\" title=\"figure 1\">",
"      Nomogram for BMI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2808|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/27/2492\" title=\"table 1\">",
"      Self administered CGA tool",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/11/2236\" title=\"table 2\">",
"      Karnofsky performance status scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/15/9467\" title=\"table 3\">",
"      ECOG performance scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/40/26252\" title=\"table 4\">",
"      Charlson risk index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/8/28811\" title=\"table 5\">",
"      Mailed geriatric assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/18/22827\" title=\"table 6\">",
"      Clinical interview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/14/18668\" title=\"table 7\">",
"      Vulnerable elders surv 13 scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?20/18/20779\" title=\"table 8\">",
"      Taxonomy of aging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/51/18237\" title=\"table 9\">",
"      Model for predicting chemotherapy toxicity in older adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/40/42636\" title=\"table 10\">",
"      Risk score versus physician-rated KPS chemo toxicity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/34/17960?source=related_link\">",
"      Clinical features and pathogenesis of cancer cachexia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/38/43624?source=related_link\">",
"      Comprehensive geriatric assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/22/31080?source=related_link\">",
"      Diagnosis of psychiatric and psychologic disorders in patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23175?source=related_link\">",
"      Dietary and nutritional assessment in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/0/30730?source=related_link\">",
"      Drug prescribing for older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/25/28057?source=related_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/26/34215?source=related_link\">",
"      Failure to thrive in elderly adults: Evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/44/43719?source=related_link\">",
"      Functional problems in the patient with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/63/5113?source=related_link\">",
"      Pharmacologic management of cancer anorexia/cachexia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/42/10922?source=related_link\">",
"      Systemic chemotherapy for cancer in elderly persons",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_56_41865="Uncommon causes of upper gastrointestinal bleeding in adults";
var content_f40_56_41865=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Uncommon causes of upper gastrointestinal bleeding in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41865/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41865/contributors\">",
"     Don C Rockey, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41865/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41865/contributors\">",
"     Mark Feldman, MD, MACP, AGAF, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/56/41865/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/56/41865/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/56/41865/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upper gastrointestinal bleeding is a common medical condition that results in substantial morbidity and mortality. The annual incidence of hospitalization for acute upper gastrointestinal bleeding appears to be approximately 100 per 100,000 individuals; in one study, the incidence was twice as common in men as in women and increased with age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/1\">",
"     1",
"    </a>",
"    ]. In a nationwide study from Spain, the incidence of hospitalization for upper gastrointestinal bleeding was six times more common than lower GI bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common causes of upper gastrointestinal bleeding include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Gastric",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      duodenal ulcers",
"     </li>",
"     <li>",
"      Esophagogastric varices",
"     </li>",
"     <li>",
"      Esophagitis",
"     </li>",
"     <li>",
"      Severe or erosive",
"      <span class=\"nowrap\">",
"       gastritis/duodenitis",
"      </span>",
"     </li>",
"     <li>",
"      Mallory-Weiss syndrome",
"     </li>",
"     <li>",
"      Angiodysplasia, including gastric antral vascular ectasia (GAVE)",
"     </li>",
"     <li>",
"      Mass lesions",
"      <span class=\"nowrap\">",
"       (polyps/cancers)",
"      </span>",
"     </li>",
"     <li>",
"      Dieulafoy's lesion",
"     </li>",
"     <li>",
"      No lesion identified",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Less common causes of upper gastrointestinal bleeding include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/8-17\">",
"     8-17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hemobilia",
"     </li>",
"     <li>",
"      Hemosuccus pancreaticus",
"     </li>",
"     <li>",
"      Aortoenteric fistula",
"     </li>",
"     <li>",
"      Cameron lesions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of the overall incidence of upper gastrointestinal bleeding is high, the less common causes of upper gastrointestinal bleeding are still frequently encountered, and as such their recognition and appropriate management are important.",
"   </p>",
"   <p>",
"    This topic will review causes of upper gastrointestinal bleeding other than peptic ulcer disease, esophagogastric varices, and Mallory-Weiss syndrome. An overall approach to the patient with upper gastrointestinal bleeding, as well as upper gastrointestinal bleeding due to peptic ulcer disease, esophagogastric varices, and Mallory-Weiss syndrome are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/23/12664?source=see_link\">",
"     \"Major causes of upper gastrointestinal bleeding in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/13/8410?source=see_link\">",
"     \"Angiodysplasia of the gastrointestinal tract\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/55/28538?source=see_link\">",
"     \"Approach to acute upper gastrointestinal bleeding in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43317?source=see_link\">",
"     \"Mallory-Weiss syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H203638978\">",
"    <span class=\"h1\">",
"     UPPER GASTROINTESTINAL TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neoplasms of the upper gastrointestinal tract account for less than 3 percent of all cases of severe upper gastrointestinal bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/18\">",
"     18",
"    </a>",
"    ]. Acute bleeding represents a late stage of disease when the neoplasm outgrows its blood supply and causes mucosal ulceration. Bleeding can result from diffuse mucosal ulceration or from erosion into an underlying vessel. Virtually any tumor type may bleed, including adenocarcinomas, gastrointestinal stromal tumors, lymphomas, and Kaposi's sarcoma. The latter should be considered in patients with HIV infection or who are immunosuppressed.",
"   </p>",
"   <p>",
"    Endoscopic findings suggestive of gastric malignancy include irregular ulcer margins and an exophytic or fungating ulcerated mass (",
"    <a class=\"graphic graphic_picture graphicRef55378 \" href=\"mobipreview.htm?43/3/44095\">",
"     picture 1",
"    </a>",
"    ). Endoscopic biopsy, brushing, or needle aspiration for histologic or cytologic examination is performed for definitive diagnosis. Endoscopic ultrasound is useful for staging local disease, while computed tomographic scanning can be helpful for staging and detection of distant metastases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=see_link\">",
"     \"Clinical features, diagnosis, and staging of gastric cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35386?source=see_link\">",
"     \"Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H203638985\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe bleeding secondary to malignant upper gastrointestinal tumors have a poor prognosis, and the majority of patients die within 12 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/18\">",
"     18",
"    </a>",
"    ]. Surgical resection for cure or palliation is the treatment of choice. Medical therapy is most often palliative and consists of chemotherapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiation therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/15/33018?source=see_link\">",
"     \"Invasive gastric cancer: Surgery and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/10/44202?source=see_link\">",
"     \"Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=see_link\">",
"     \"Adjuvant and neoadjuvant treatment of gastric cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endoscopic treatments for bleeding upper gastrointestinal tumors include injection therapy, thermal contact probes (bipolar probes, or heater probe), and laser therapy. If endoscopic hemostasis can be achieved, it is generally only a temporizing measure prior to staging and surgical resection. Control of active bleeding can be successful, but rebleeding is common from nonhealing, malignant ulcers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIEULAFOY'S LESION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A Dieulafoy's lesion is a dilated aberrant submucosal vessel that erodes the overlying epithelium in the absence of a primary ulcer (",
"    <a class=\"graphic graphic_picture graphicRef76996 \" href=\"mobipreview.htm?34/59/35774\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/3\">",
"     3",
"    </a>",
"    ]. The submucosal artery does not undergo normal branching within the wall of the stomach. As a result, the caliber of the artery is in the range of 1 to 3 mm, approximately 10 times the normal caliber of mucosal capillaries. Dieulafoy's lesions are usually located in the proximal stomach along the lesser curvature near the esophagogastric junction (typically within 5 cm of the esophagogastric junction), although they have been found in all areas of the gastrointestinal tract, including the esophagus, duodenum, and colon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/3,19-22\">",
"     3,19-22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The etiology of Dieulafoy's lesion is unknown. Additionally, events triggering bleeding are not well-understood. Patients who bleed from Dieulafoy's lesions are typically men with comorbidities including cardiovascular disease, hypertension, chronic kidney disease, diabetes, or alcohol abuse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/22\">",
"     22",
"    </a>",
"    ]. The use of nonsteroidal anti-inflammatory drugs (NSAIDS) is also common among patients with bleeding; one theory is that NSAIDS incite bleeding by causing mucosal atrophy and ischemic injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/3\">",
"     3",
"    </a>",
"    ]. Bleeding is often self-limited, although it is usually recurrent and can be profuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopy is the diagnostic modality of choice for a Dieulafoy's lesion during acute bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Active arterial pumping may be visualized in an area without an associated ulcer or mass lesion. In the absence of active bleeding, it may look like a raised nipple or visible vessel without an associated ulcer; however, the aberrant vessel is often not seen unless there is active bleeding from the site. Endoscopic ultrasonography may also be useful in confirming the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of approaches have been shown to be effective for the treatment of Dieulafoy's lesions. Endoscopic hemostasis with a combination of epinephrine injection followed by bipolar probe coagulation (",
"    <a class=\"graphic graphic_picture graphicRef73328 \" href=\"mobipreview.htm?16/12/16582\">",
"     picture 3",
"    </a>",
"    ), heater probe thermal coagulation, or hemoclip placement to control acute bleeding and to prevent rebleeding is effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/25-30\">",
"     25-30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other approaches that have been used successfully to treat Dieulafoy's lesions include endoscopic band ligation and argon plasma coagulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/26,28,31-35\">",
"     26,28,31-35",
"    </a>",
"    ]. However, endoscopic band ligation should be used with caution in this setting because it has been associated with perforation (especially where the ligated gastric wall is thin, such as the fundus) and bleeding from the resulting ulcer once the band falls off; a fatality from such an ulcer has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/25,31\">",
"     25,31",
"    </a>",
"    ]. Similarly, band ligation is probably unsafe in the small bowel and right colon since it may entrap the serosa and thereby lead to perforation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/15/24826?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of the treatment of bleeding peptic ulcers\", section on 'Endoscopic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Doppler ultrasound has been used to confirm ablation of a Dieulafoy's lesion by documenting the absence of blood flow following injection therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/37\">",
"     37",
"    </a>",
"    ]. Endoscopic tattooing with India ink injections is helpful for locating the lesion for further endoscopic retreatment or intraoperative wedge resection (",
"    <a class=\"graphic graphic_picture graphicRef73328 \" href=\"mobipreview.htm?16/12/16582\">",
"     picture 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/51/30519?source=see_link\">",
"     \"Tattooing and other methods for localizing colonic lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If rebleeding occurs after one endoscopic treatment, therapeutic options include repeat endoscopic hemostasis, angiographic embolization, or surgical wedge resection of the lesion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/38\">",
"     38",
"    </a>",
"    ]. A combined endoscopic and laparoscopic approach has been described; this approach allows precise location of the lesion with intraoperative endoscopy, followed by a limited laparoscopic surgical wedge resection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/39\">",
"     39",
"    </a>",
"    ]. There is no further risk of rebleeding from a Dieulafoy's lesion after surgical wedge resection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/2/24616?source=see_link\">",
"     \"Angiographic control of nonvariceal gastrointestinal bleeding in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Few studies have compared the various approaches, so treatment should be based upon local experience and expertise. In most instances, the initial approach to rebleeding should be aggressive endoscopy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angiography. Surgical resection should be reserved for difficult-to-control bleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     GASTRIC ANTRAL VASCULAR ECTASIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric antral vascular ectasia (GAVE or watermelon stomach) is an uncommon cause of upper gastrointestinal bleeding that is often confused with portal hypertensive gastropathy, both of which can occur in patients with cirrhosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Portal hypertensive gastropathy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The term watermelon stomach is derived from the characteristic endoscopic appearance of longitudinal rows of flat, reddish stripes radiating from the pylorus into the antrum that resemble the stripes on a watermelon (",
"    <a class=\"graphic graphic_picture graphicRef67415 \" href=\"mobipreview.htm?18/61/19408\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/4\">",
"     4",
"    </a>",
"    ]. The red stripes represent ectatic and sacculated mucosal vessels. A punctate form (in which the red stripes are not apparent) has also been described and appears to be more common in patients with underlying cirrhosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    GAVE is thought to occur in an idiopathic fashion. However, it has been associated with cirrhosis and systemic sclerosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/40,42\">",
"     40,42",
"    </a>",
"    ]. Bleeding was due to GAVE in 4 percent of 744 consecutive patients with nonvariceal upper gastrointestinal bleeding in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/43\">",
"     43",
"    </a>",
"    ]. Eight of these patients (31 percent) also had portal hypertension. The most common clinical profile of the patient with GAVE is an elderly (&gt;70 years old) female with iron deficiency anemia, slow GI blood loss, and no history of cirrhosis. In the series described above, for example, the median age was 74 and 80 percent were women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bleeding is most often chronic, with patients presenting with occult blood in the stool, with or without iron deficiency anemia. The clinical presentation is similar whether portal hypertension is present or not, except that those with portal hypertension may have diffuse antral angiomas rather than the classic linear pattern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis is based upon the classic endoscopic appearance. It may be confirmed with endoscopic biopsy, endoscopic ultrasound, tagged red blood cell scan, or computed tomographic scan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Histopathologically, GAVE is characterized by vascular ectasia, spindle cell proliferation, and fibrohyalinosis (",
"    <a class=\"graphic graphic_picture graphicRef76145 \" href=\"mobipreview.htm?22/44/23237\">",
"     picture 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Episodic transfusions are required in some chronic cases, but the bleeding is rarely acute and massive. Endoscopic coagulation with a heater probe, bipolar probe, argon plasma coagulator, or laser therapy obliterates the vascular ectasia and decreases the degree of bleeding (",
"    <a class=\"graphic graphic_picture graphicRef54724 graphicRef56249 \" href=\"mobipreview.htm?26/32/27144\">",
"     picture 6A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/43,46\">",
"     43,46",
"    </a>",
"    ]. Endoscopic band ligation has also been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/47\">",
"     47",
"    </a>",
"    ].(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34695?source=see_link\">",
"     \"Argon plasma coagulation in the management of gastrointestinal hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Importantly, portal decompression with transjugular intrahepatic portosystemic shunt (TIPS) does",
"    <strong>",
"     not",
"    </strong>",
"    reliably reduce bleeding, underscoring the uncertain relationship of GAVE to portal hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Antrectomy prevents recurrent bleeding but is usually reserved for patients who fail endoscopic therapies. Combination",
"    <span class=\"nowrap\">",
"     estrogen/progesterone",
"    </span>",
"    therapy may decrease bleeding, although the ectatic vessels appear to persist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PORTAL HYPERTENSIVE GASTROPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Portal hypertensive gastropathy (congestive gastropathy), while extremely common in patients with portal hypertension, is an uncommon cause of significant bleeding in these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/51\">",
"     51",
"    </a>",
"    ]. When portal hypertensive gastropathy is the sole cause of bleeding, there is diffuse mucosal oozing with no other lesions, such as varices, to account for the GI bleeding and anemia.",
"   </p>",
"   <p>",
"    The mucosa is friable, and bleeding presumably occurs when the ectatic vessels rupture. The severity of gastropathy is related to the level of portal pressure, the level of hepatic vascular resistance, and the degree of reduction in hepatic blood flow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Portal hypertensive gastropathy may correlate with the severity of liver disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/53\">",
"     53",
"    </a>",
"    ]. Gastric mucosal blood flow is increased in patients with cirrhosis and portal hypertensive gastropathy compared with those without the gastropathy, suggesting that the pathogenesis of this disorder may be related to both congestion and hyperemia in the stomach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Mucosal ischemia and increased nitric oxide synthase activity have been identified in portal hypertensive gastropathy, but their etiologic role is uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. There does not appear to be a relationship with",
"    <em>",
"     Helicobacter pylori",
"    </em>",
"    infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/58,59\">",
"     58,59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some studies have suggested that endoscopic sclerotherapy or ligation of esophageal varices increases the risk of developing portal hypertensive gastropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/58,60\">",
"     58,60",
"    </a>",
"    ]. In a prospective review, 107 patients with portal hypertension of various causes were studied before and after sclerotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/61\">",
"     61",
"    </a>",
"    ]. Portal hypertensive gastropathy was evident in 4 of 35 patients with cirrhosis before sclerotherapy, but was not seen in patients without cirrhosis. After sclerotherapy, 21 additional patients (20 percent) developed portal hypertensive gastropathy during a follow-up of 23 months. The risk of this complication was significantly influenced by prior sclerotherapy, the severity of liver disease, the etiology of portal hypertension, and the coexistence of gastric varices; it was not directly correlated with intravariceal pressure. It has been hypothesized that variceal obliteration results in hyperdynamic congestion, which gives rise to portal hypertensive gastropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;At the time of endoscopy, portal hypertensive gastropathy characteristically appears as a fine white reticular pattern separating areas of pinkish mucosa, giving the gastric mucosa a \"snakeskin\" appearance (",
"    <a class=\"graphic graphic_picture graphicRef75725 \" href=\"mobipreview.htm?35/5/35935\">",
"     picture 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/4\">",
"     4",
"    </a>",
"    ]. Mucosal changes are usually most evident in the fundus and body. However, in more severe cases, oozing, bleeding, subepithelial hemorrhages, and increased vascularity similar to angiomas are evident, often involving the gastric fundus, gastric body, and antrum. Pathologic examination reveals extensive edema in more severe cases, with capillary and venous dilatation in the submucosa extending into the mucosa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Natural history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The natural history of portal hypertensive gastropathy was evaluated in a study that included 315 patients who were followed with clinical and endoscopic examinations every six months for three years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/51\">",
"     51",
"    </a>",
"    ]. During follow-up, the gastropathy remained stable in 29 percent, deteriorated in 23 percent, improved in 23 percent, and fluctuated in 25 percent. Acute bleeding from the gastropathy was observed in only eight patients (2.5 percent), with one death. Chronic bleeding occurred in 34 patients (11 percent).",
"   </p>",
"   <p>",
"    Similar observations were made in another study of 222 cirrhotic patients who underwent upper endoscopy every 12 months for an average of 47 months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/62\">",
"     62",
"    </a>",
"    ]. Upon enrollment, 48 patients had portal gastropathy, the presence of which was predicted by the presence of esophageal varices. In the remaining patients, the incidence of portal hypertensive gastropathy was estimated to be 3 percent at one year and 24 percent at three years. During follow-up, 16 patients bled from portal gastropathy (9 acutely and 7 chronically), including one who exsanguinated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of bleeding from portal hypertensive gastropathy is directed at decreasing portal pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/54\">",
"     54",
"    </a>",
"    ]. This may be accomplished by a variety of measures, including transjugular intrahepatic portosystemic shunt (TIPS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/63,64\">",
"     63,64",
"    </a>",
"    ], portacaval shunt surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/65\">",
"     65",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/66\">",
"     66",
"    </a>",
"    ], and liver transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/67\">",
"     67",
"    </a>",
"    ]. In one trial, propranolol reduced the rate of recurrent bleeding compared with placebo in patients with portal hypertensive gastropathy (35 versus 62 percent at one year) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/66\">",
"     66",
"    </a>",
"    ]. Pharmacologic agents that decrease splanchnic blood flow, such as vasopressin, somatostatin, or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    , may also decrease bleeding from portal hypertensive gastropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/68\">",
"     68",
"    </a>",
"    ], but their efficacy has not been studied in randomized trials for this indication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/69,70\">",
"     69,70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Limited information on the efficacy of TIPS for portal hypertensive gastropathy is available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/49,54\">",
"     49,54",
"    </a>",
"    ]. In one series involving 40 patients, TIPS was associated with an improvement in endoscopic findings and a decrease in transfusion requirement in 89 and 75 percent of patients with mild and severe portal hypertensive gastropathy, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/54\">",
"     54",
"    </a>",
"    ]. Endoscopic improvement in patients with mild gastropathy was visible within six weeks in most patients, and by three to six months in approximately 85 percent of patients. The response was slower in patients with severe gastropathy. However, more than two-thirds had endoscopic improvement by three months.",
"   </p>",
"   <p>",
"    Endoscopic thermal coagulation may be effective for focally bleeding angiomas associated with cirrhosis. By contrast, banding, injection therapy, H2-blockers, and topical agents such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/29/29141?source=see_link\">",
"     sucralfate",
"    </a>",
"    are ineffective for controlling diffuse bleeding or for preventing rebleeding from extensive portal hypertensive gastropathy.",
"   </p>",
"   <p>",
"    Most experts recommend therapy with a non-selective beta blocker such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    first, and if that fails and bleeding is severe, TIPS. If bleeding continues, portacaval shunt surgery is performed. Liver transplantation should be considered early in the treatment algorithm if the patient has decompensated liver disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/61/25559?source=see_link\">",
"     \"Patient selection for liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     HEMOBILIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemobilia, or bleeding from the hepatobiliary tract, is a rare cause of acute upper gastrointestinal bleeding. It should be considered in a patient with acute upper gastrointestinal bleeding and a recent history of hepatic parenchymal or biliary tract instrumentation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    injury, including percutaneous and transjugular liver biopsy, [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/8-11\">",
"     8-11",
"    </a>",
"    ], percutaneous transhepatic cholangiogram [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/71,72\">",
"     71,72",
"    </a>",
"    ], cholecystectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/73\">",
"     73",
"    </a>",
"    ], endoscopic biliary biopsies or stenting, transjugular intrahepatic portosystemic shunt (TIPS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/74\">",
"     74",
"    </a>",
"    ], angioembolization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/75\">",
"     75",
"    </a>",
"    ], or blunt abdominal trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/76\">",
"     76",
"    </a>",
"    ]. Other causes of hemobilia include gallstones, cholecystitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/77\">",
"     77",
"    </a>",
"    ], hepatic or bile duct tumors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/78\">",
"     78",
"    </a>",
"    ], intrahepatic stents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/79,80\">",
"     79,80",
"    </a>",
"    ], hepatic artery aneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/81\">",
"     81",
"    </a>",
"    ], and hepatic abscesses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/81,82\">",
"     81,82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The classic triad of hemobilia includes biliary colic, obstructive jaundice, and occult or acute GI bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/83\">",
"     83",
"    </a>",
"    ], but is uncommonly present. Obstructive jaundice, with or without biliary sepsis, may occur if blood clots within the biliary system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of hemobilia is often overlooked in the absence of active bleeding seen at the papilla. A side-viewing duodenoscope is helpful for visualizing the ampulla or for performing diagnostic endoscopic retrograde cholangiography (ERCP) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/84\">",
"     84",
"    </a>",
"    ]. Technetium-tagged red blood cell scan or selective hepatic artery angiography may reveal the source of hemobilia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/85\">",
"     85",
"    </a>",
"    ]. Our approach is to first perform ERCP to confirm the diagnosis and then proceed to arteriography for treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is directed at the primary cause of bleeding, such as embolization or surgical resection of a hepatic tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/86\">",
"     86",
"    </a>",
"    ]. In the case of bleeding following liver biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/10,87\">",
"     10,87",
"    </a>",
"    ], laparoscopic cholecystectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/88\">",
"     88",
"    </a>",
"    ], or percutaneous transhepatic cholangiogram [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/89\">",
"     89",
"    </a>",
"    ], arterial embolization is often employed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/2/24616?source=see_link&amp;anchor=H4#H4\">",
"     \"Angiographic control of nonvariceal gastrointestinal bleeding in adults\", section on 'Embolization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     HEMOSUCCUS PANCREATICUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemosuccus pancreaticus, or bleeding from the pancreatic duct, is another rare cause of upper gastrointestinal bleeding. It is most often found in patients with chronic pancreatitis, pancreatic pseudocysts, or pancreatic tumors. Bleeding occurs when a pseudocyst or tumor erodes into a vessel, typically a pseudoaneurysm, forming a direct communication between the pancreatic duct and vessel. It may also be found after therapeutic endoscopy of the pancreas or pancreatic duct, including pancreatic stone removal, pancreatic duct sphincterotomy, pseudocyst drainage, or pancreatic duct stenting. Bleeding is often aggressive and may be life threatening.",
"   </p>",
"   <p>",
"    Hemosuccus pancreaticus should be suspected clinically when upper gastrointestinal bleeding occurs in one of the above settings in which pancreatic injury is present. The diagnosis is usually best confirmed with abdominal computed tomographic (CT) scanning",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angiography, although endoscopic retrograde cholangiopancreatography or intraoperative exploration may also be helpful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Abdominal CT scanning is usually performed first because it is the least invasive modality. Mesenteric arteriography with coil embolization can control acute bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/12\">",
"     12",
"    </a>",
"    ]. If bleeding persists or is massive, treatment is with pancreaticoduodenectomy or pseudocyst resection and ligation of the bleeding vessel, which definitively prevent rebleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/90,91\">",
"     90,91",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     AORTOENTERIC FISTULAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortoenteric fistulas are a rare cause of acute upper gastrointestinal bleeding but are associated with high mortality if undiagnosed and untreated. The third or fourth portion of the duodenum is the most common site for aortoenteric fistulas, followed by the jejunum and ileum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients present with an initial herald bleed that is manifested by hematemesis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hematochezia; this may be followed by massive bleeding and exsanguination. Intermittent bleeding can be seen if a blood clot temporarily seals the fistula. Other signs and symptoms may include abdominal or back pain, fever, and sepsis. Infrequently, an abdominal mass is palpable or an abdominal bruit is heard.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortoenteric fistulas arise from direct communication between the aorta and the gastrointestinal tract. The most common cause of primary aortoenteric fistulas in the United States is an atherosclerotic aortic aneurysm. Causes reported in other parts of the world include infectious aortitis due to syphilis or tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/92-96\">",
"     92-96",
"    </a>",
"    ]. The classic presentation is a patient with massive gastrointestinal bleeding, a pulsatile abdominal mass, and abdominal (or back) pain. However, this triad was present in only 11 percent of 81 patients in one review [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/96\">",
"     96",
"    </a>",
"    ]. Most cases were heralded by repetitive gastrointestinal bleeding.",
"   </p>",
"   <p>",
"    The most common cause of secondary aortoenteric fistulas is a prosthetic abdominal aortic vascular graft [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/97,98\">",
"     97,98",
"    </a>",
"    ]. Pressure necrosis and graft infection have been implicated in the development of fistulas in this setting. This complication has become less common with the implementation of careful preventive measures when the graft is placed. Other secondary causes include penetrating ulcers, tumor invasion, trauma, radiation therapy, and foreign body perforation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/99,100\">",
"     99,100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A high index of suspicion is needed to establish the diagnosis of an aortoenteric fistula. This disorder should be considered in all patients with massive or repetitive upper gastrointestinal bleeding and a history of a thoracic or abdominal aortic aneurysm or a prosthetic vascular graft.",
"   </p>",
"   <p>",
"    Endoscopy is important primarily to exclude other causes of acute upper gastrointestinal bleeding, such as ulcer disease. The best diagnostic test is abdominal computed tomographic scanning, which often shows an aortic phlegmon in the area of the third or fourth portion of the duodenum. Endoscopy with an enteroscope or side-viewing endoscope may reveal a graft, an ulcer or erosion at the adherent clot, or an extrinsic pulsatile mass in the distal duodenum or esophagus. Aortography is typically unreliable and not recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/14,94\">",
"     14,94",
"    </a>",
"    ]. Exploratory laparotomy is indicated for patients with suspected aortoenteric fistula and severe ongoing bleeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mortality rate of an untreated aortoenteric fistula that presents with upper gastrointestinal hemorrhage is nearly 100 percent. Surgical repair of the aortic aneurysm and fistula is the standard treatment regardless of the cause.",
"   </p>",
"   <p>",
"    Therapy of an aortoenteric fistula due to an infected graft consists of intravenous antibiotics and emergency surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/14,94\">",
"     14,94",
"    </a>",
"    ]. The standard surgical procedure is removal of the infected graft and extra-anatomic bypass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/98\">",
"     98",
"    </a>",
"    ]. Infected graft removal with in situ graft replacement has been proposed as an alternative treatment, but comparative data are lacking to establish its relative safety and efficacy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     CAMERON LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cameron lesions are erosions or ulcers occurring in the sac of a hiatal hernia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. They have been described in up to 5 percent of patients with a hiatal hernia who undergo upper endoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/17\">",
"     17",
"    </a>",
"    ]. They are usually an incidental finding but rarely can cause acute or chronic upper gastrointestinal bleeding and iron deficiency anemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/101-103\">",
"     101-103",
"    </a>",
"    ]. Their pathogenesis is incompletely understood. Potential contributing factors include reflux esophagitis and mechanical trauma.",
"   </p>",
"   <p>",
"    The diagnosis is made with upper endoscopy. Management depends upon the clinical setting and should thus be individualized. Acute bleeding can be treated endoscopically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/104\">",
"     104",
"    </a>",
"    ]. Patients with iron deficiency from chronic bleeding can be treated with a proton pump inhibitor after iron repletion, which may help prevent recurrence of anemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/56/41865/abstract/105\">",
"     105",
"    </a>",
"    ]. Surgery to repair the hiatal hernia can be considered in patients with recurrent bleeding despite the above measures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of bleeding peptic ulcers may have declined in recent decades, making uncommon causes of gastrointestinal bleeding relatively more common.",
"     </li>",
"     <li>",
"      The most common causes of upper gastrointestinal bleeding include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Gastric",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      duodenal ulcers",
"     </li>",
"     <li>",
"      Esophagogastric varices",
"     </li>",
"     <li>",
"      Esophagitis",
"     </li>",
"     <li>",
"      Severe or erosive",
"      <span class=\"nowrap\">",
"       gastritis/duodenitis",
"      </span>",
"     </li>",
"     <li>",
"      Mallory-Weiss syndrome",
"     </li>",
"     <li>",
"      Angiodysplasia, including gastric antral vascular ectasia (GAVE)",
"     </li>",
"     <li>",
"      Mass lesions",
"      <span class=\"nowrap\">",
"       (polyps/cancers)",
"      </span>",
"     </li>",
"     <li>",
"      Dieulafoy's lesion",
"     </li>",
"     <li>",
"      No lesion identified",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Less common causes of upper gastrointestinal bleeding include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Hemobilia",
"     </li>",
"     <li>",
"      Hemosuccus pancreaticus",
"     </li>",
"     <li>",
"      Aortoenteric fistula",
"     </li>",
"     <li>",
"      Cameron's ulcer",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Many of the sources of upper gastrointestinal bleeding are apparent on endoscopic studies, though some require heightened clinical suspicion and specific testing.",
"     </li>",
"     <li>",
"      Care of patients with upper GI bleeding from any cause should include general measures such as appropriate resuscitation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/55/28538?source=see_link\">",
"       \"Approach to acute upper gastrointestinal bleeding in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H809058756\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and UpToDate would like to thank Drs. Rome Jutabha and Dennis Jensen, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/1\">",
"      Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995; 90:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/2\">",
"      Lanas A, Perez-Aisa MA, Feu F, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005; 100:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/3\">",
"      Lee YT, Walmsley RS, Leong RW, Sung JJ. Dieulafoy's lesion. Gastrointest Endosc 2003; 58:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/4\">",
"      Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am 1996; 80:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/5\">",
"      Boonpongmanee S, Fleischer DE, Pezzullo JC, et al. The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc 2004; 59:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/6\">",
"      Enestvedt BK, Gralnek IM, Mattek N, et al. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc 2008; 67:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/7\">",
"      Balderas V, Bhore R, Lara LF, et al. The hematocrit level in upper gastrointestinal hemorrhage: safety of endoscopy and outcomes. Am J Med 2011; 124:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/8\">",
"      Counihan TC, Islam S, Swanson RS. Acute cholecystitis resulting from hemobilia after tru-cut biopsy: a case report and brief review of the literature. Am Surg 1996; 62:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/9\">",
"      Jabbour N, Reyes J, Zajko A, et al. Arterioportal fistula following liver biopsy. Three cases occurring in liver transplant recipients. Dig Dis Sci 1995; 40:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/10\">",
"      Murata K, Oohashi Y, Takase K, et al. A case of hemobilia after percutaneous liver biopsy treated by transcatheter arterial embolization with Histoacryl. Am J Gastroenterol 1996; 91:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/11\">",
"      Van Os EC, Petersen BT. Pancreatitis secondary to percutaneous liver biopsy-associated hemobilia. Am J Gastroenterol 1996; 91:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/12\">",
"      Suter M, Doenz F, Chapuis G, et al. Haemorrhage into the pancreatic duct (Hemosuccus pancreaticus): recognition and management. Eur J Surg 1995; 161:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/13\">",
"      Risti B, Marincek B, Jost R, et al. Hemosuccus pancreaticus as a source of obscure upper gastrointestinal bleeding: three cases and literature review. Am J Gastroenterol 1995; 90:1878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/14\">",
"      Antinori CH, Andrew CT, Santaspirt JS, et al. The many faces of aortoenteric fistulas. Am Surg 1996; 62:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/15\">",
"      Cameron AJ. Incidence of iron deficiency anemia in patients with large diaphragmatic hernia. A controlled study. Mayo Clin Proc 1976; 51:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/16\">",
"      Cameron AJ, Higgins JA. Linear gastric erosion. A lesion associated with large diaphragmatic hernia and chronic blood loss anemia. Gastroenterology 1986; 91:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/17\">",
"      Weston AP. Hiatal hernia with cameron ulcers and erosions. Gastrointest Endosc Clin N Am 1996; 6:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/18\">",
"      Savides TJ, Jensen DM, Cohen J, et al. Severe upper gastrointestinal tumor bleeding: endoscopic findings, treatment, and outcome. Endoscopy 1996; 28:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/19\">",
"      Pollack R, Lipsky H, Goldberg RI. Duodenal Dieulafoy's lesion. Gastrointest Endosc 1993; 39:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/20\">",
"      Anireddy D, Timberlake G, Seibert D. Dieulafoy's lesion of the esophagus. Gastrointest Endosc 1993; 39:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/21\">",
"      Choudari CP, Palmer KR. Dieulafoy's lesion of the duodenum; successful endoscopic therapy. Endoscopy 1993; 25:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/22\">",
"      Lara LF, Sreenarasimhaiah J, Tang SJ, et al. Dieulafoy lesions of the GI tract: localization and therapeutic outcomes. Dig Dis Sci 2010; 55:3436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/23\">",
"      Kaufman Z, Liverant S, Shiptz B, Dinbar A. Massive gastrointestinal bleeding caused by Dieulafoy's lesion. Am Surg 1995; 61:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/24\">",
"      Squillace SJ, Johnson DA, Sanowski RA. The endosonographic appearance of a Dieulafoy's lesion. Am J Gastroenterol 1994; 89:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/25\">",
"      Chen YY, Su WW, Soon MS, Yen HH. Delayed fatal hemorrhage after endoscopic band ligation for gastric Dieulafoy's lesion. Gastrointest Endosc 2005; 62:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/26\">",
"      Liu D, Lu F, Ou D, et al. [Endoscopic band ligation versus endoscopic hemoclip placement for bleeding due to Dieulafoy lesions in the upper gastrointestinal tract]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009; 34:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/27\">",
"      Becker SA, Ellger R, Buyeuiz V. Hemoclip placement as definitive therapy for bleeding from a dieulafoy lesion. Isr Med Assoc J 2002; 4:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/28\">",
"      Dulic-Lakovic E, Dulic M, Hubner D, et al. Bleeding Dieulafoy lesions of the small bowel: a systematic study on the epidemiology and efficacy of enteroscopic treatment. Gastrointest Endosc 2011; 74:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/29\">",
"      Park CH, Sohn YH, Lee WS, et al. The usefulness of endoscopic hemoclipping for bleeding Dieulafoy lesions. Endoscopy 2003; 35:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/30\">",
"      Yamaguchi Y, Yamato T, Katsumi N, et al. Short-term and long-term benefits of endoscopic hemoclip application for Dieulafoy's lesion in the upper GI tract. Gastrointest Endosc 2003; 57:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/31\">",
"      Matsui S, Kamisako T, Kudo M, Inoue R. Endoscopic band ligation for control of nonvariceal upper GI hemorrhage: comparison with bipolar electrocoagulation. Gastrointest Endosc 2002; 55:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/32\">",
"      Iacopini F, Petruzziello L, Marchese M, et al. Hemostasis of Dieulafoy's lesions by argon plasma coagulation (with video). Gastrointest Endosc 2007; 66:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/33\">",
"      Mumtaz R, Shaukat M, Ramirez FC. Outcomes of endoscopic treatment of gastroduodenal Dieulafoy's lesion with rubber band ligation and thermal/injection therapy. J Clin Gastroenterol 2003; 36:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/34\">",
"      McGrath K, Mergener K, Branch S. Endoscopic band ligation of Dieulafoy's lesion: report of two cases and review of the literature. Am J Gastroenterol 1999; 94:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/35\">",
"      Brown GR, Harford WV, Jones WF. Endoscopic band ligation of an actively bleeding Dieulafoy lesion. Gastrointest Endosc 1994; 40:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/36\">",
"      Barker KB, Arnold HL, Fillman EP, et al. Safety of band ligator use in the small bowel and the colon. Gastrointest Endosc 2005; 62:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/37\">",
"      Jaspersen D. Dieulafoy's disease controlled by Doppler ultrasound endoscopic treatment. Gut 1993; 34:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/38\">",
"      Baxter M, Aly EH. Dieulafoy's lesion: current trends in diagnosis and management. Ann R Coll Surg Engl 2010; 92:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/39\">",
"      Bouillot JL, Aubertin JM, Fornes P, et al. Dieulafoy's ulcer: combined endoscopic and laparoscopic treatment. Endoscopy 1996; 28:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/40\">",
"      Payen JL, Cal&egrave;s P, Voigt JJ, et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology 1995; 108:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/41\">",
"      Ito M, Uchida Y, Kamano S, et al. Clinical comparisons between two subsets of gastric antral vascular ectasia. Gastrointest Endosc 2001; 53:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/42\">",
"      Watson M, Hally RJ, McCue PA, et al. Gastric antral vascular ectasia (watermelon stomach) in patients with systemic sclerosis. Arthritis Rheum 1996; 39:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/43\">",
"      Dulai GS, Jensen DM, Kovacs TO, et al. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy 2004; 36:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/44\">",
"      Herman BE, Vargo JJ, Baum S, et al. Gastric antral vascular ectasia: a case report and review of the literature. J Nucl Med 1996; 37:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/45\">",
"      Barnard GF, Colby JM, Saltzman JR, et al. Endoscopic ultrasound appearance of watermelon stomach. Abdom Imaging 1995; 20:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/46\">",
"      Ng I, Lai KC, Ng M. Clinical and histological features of gastric antral vascular ectasia: successful treatment with endoscopic laser therapy. J Gastroenterol Hepatol 1996; 11:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/47\">",
"      Wells CD, Harrison ME, Gurudu SR, et al. Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc 2008; 68:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/48\">",
"      Spahr L, Villeneuve JP, Dufresne MP, et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999; 44:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/49\">",
"      Kamath PS, Lacerda M, Ahlquist DA, et al. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/50\">",
"      Manning RJ. Estrogen/progesterone treatment of diffuse antral vascular ectasia. Am J Gastroenterol 1995; 90:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/51\">",
"      Primignani M, Carpinelli L, Preatoni P, et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 2000; 119:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/52\">",
"      Iwao T, Toyonaga A, Sumino M, et al. Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology 1992; 102:2060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/53\">",
"      Fontana RJ, Sanyal AJ, Mehta S, et al. Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am J Gastroenterol 2006; 101:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/54\">",
"      Trevino HH, Brady CE 3rd, Schenker S. Portal hypertensive gastropathy. Dig Dis 1996; 14:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/55\">",
"      Ohta M, Hashizume M, Higashi H, et al. Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 1994; 20:1432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/56\">",
"      El-Newihi HM, Kanji VK, Mihas AA. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy. Am J Gastroenterol 1996; 91:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/57\">",
"      Piasecki C, Chin J, Greenslade L, et al. Endoscopic detection of ischaemia with a new probe indicates low oxygenation of gastric epithelium in portal hypertensive gastropathy. Gut 1995; 36:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/58\">",
"      Yachha SK, Ghoshal UC, Gupta R, et al. Portal hypertensive gastropathy in children with extrahepatic portal venous obstruction: role of variceal obliteration by endoscopic sclerotherapy and Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 1996; 23:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/59\">",
"      Balan KK, Jones AT, Roberts NB, et al. The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver. Am J Gastroenterol 1996; 91:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/60\">",
"      Hou MC, Lin HC, Kuo BI, et al. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology 1995; 21:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/61\">",
"      Sarin SK, Sreenivas DV, Lahoti D, Saraya A. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology 1992; 102:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/62\">",
"      Merli M, Nicolini G, Angeloni S, et al. The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol 2004; 99:1959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/63\">",
"      Lafortune M, Martinet JP, Denys A, et al. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study. AJR Am J Roentgenol 1995; 164:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/64\">",
"      Stanley AJ, Jalan R, Forrest EH, et al. Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut 1996; 39:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/65\">",
"      Orloff MJ, Orloff MS, Orloff SL, et al. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg 1995; 180:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/66\">",
"      P&eacute;rez-Ayuso RM, Piqu&eacute; JM, Bosch J, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991; 337:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/67\">",
"      DeWeert TM, Gostout CJ, Wiesner RH. Congestive gastropathy and other upper endoscopic findings in 81 consecutive patients undergoing orthotopic liver transplantation. Am J Gastroenterol 1990; 85:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/68\">",
"      Iwao T, Toyonaga A, Shigemori H, et al. Vasopressin plus oxygen vs vasopressin alone in cirrhotic patients with portal-hypertensive gastropathy: effects on gastric mucosal haemodynamics and oxygenation. J Gastroenterol Hepatol 1996; 11:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/69\">",
"      Sung JJ, Chung SC, Yung MY, et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995; 346:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/70\">",
"      Cubillas R, Rockey DC. Portal hypertensive gastropathy: a review. Liver Int 2010; 30:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/71\">",
"      Goodwin SC, Stainken BF, McNamara TO, Yoon HC. Prevention of significant hemobilia during placement of transhepatic biliary drainage catheters: technique modification and initial results. J Vasc Interv Radiol 1995; 6:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/72\">",
"      Savader SJ, Trerotola SO, Merine DS, et al. Hemobilia after percutaneous transhepatic biliary drainage: treatment with transcatheter embolotherapy. J Vasc Interv Radiol 1992; 3:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/73\">",
"      Yelle JD, Fairfull-Smith R, Rasuli P, Lorimer JW. Hemobilia complicating elective laparoscopic cholecystectomy: a case report. Can J Surg 1996; 39:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/74\">",
"      Menzel J, Vestring T, Foerster EC, et al. Arterio-biliary fistula after transjugular intrahepatic portosystemic shunt: a life-threatening complication of the new technique for therapy of portal hypertension. Z Gastroenterol 1995; 33:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/75\">",
"      Moreno RD, Harris M, Bryk HB, et al. Late presentation of a hepatic pseudoaneurysm with hemobilia after angioembolization for blunt hepatic trauma. J Trauma 2007; 62:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/76\">",
"      de Souza AL, Seguro AC. Gram staining: an unexplored diagnostic tool for diagnosis of meningococcal infection in the developing world. J Emerg Med 2009; 37:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/77\">",
"      Willemsen PJ, Vanderveken ML, De Caluwe DO, Tielliu IF. Hemobilia: a rare complication of cholecystitis and cholecystolithiasis. Case report. Acta Chir Belg 1996; 96:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/78\">",
"      Osawa H, Mori Y, Inoue F. Case report: malignant haemobilia detected in the gallbladder--retrograde cholangiographic findings. Br J Radiol 1996; 69:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/79\">",
"      Monroe PS, Deeter WT, Rizk P. Delayed hemobilia secondary to expandable metal stent. Gastrointest Endosc 1993; 39:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/80\">",
"      Stoker J, Lam&eacute;ris JS, van Blankenstein M. Percutaneous metallic self-expandable endoprostheses in malignant hilar biliary obstruction. Gastrointest Endosc 1993; 39:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/81\">",
"      Liou TC, Ling CC, Pang KK. Liver abscess concomitant with hemobilia due to rupture of hepatic artery aneurysm: a case report. Hepatogastroenterology 1996; 43:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/82\">",
"      Awasthy N, Juneja M, Talukdar B, Puri AS. Hemobilia complicating a liver abcess. J Trop Pediatr 2007; 53:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/83\">",
"      Bloechle C, Izbicki JR, Rashed MY, et al. Hemobilia: presentation, diagnosis, and management. Am J Gastroenterol 1994; 89:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/84\">",
"      Sherman S, Jamidar P, Shaked A, et al. Biliary tract complications after orthotopic liver transplantation. Endoscopic approach to diagnosis and therapy. Transplantation 1995; 60:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/85\">",
"      Spieth ME, Hou CC, Ewing PD, et al. Hemobilia presenting as intermittent gastrointestinal hemorrhage with sincalide confirmation. A case report. Clin Nucl Med 1995; 20:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/86\">",
"      Kotoh K, Satoh M, Kyoda S, et al. Successful control of hemobilia secondary to metastatic liver cancer with transcatheter arterial embolization. Am J Gastroenterol 1991; 86:1642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/87\">",
"      Grieco A, Bianco A, Pieri S, et al. Massive haemobilia after percutaneous liver biopsy in a patient with POEMS syndrome successfully treated by arterial embolization. Eur J Gastroenterol Hepatol 1996; 8:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/88\">",
"      Rivitz SM, Waltman AC, Kelsey PB. Embolization of an hepatic artery pseudoaneurysm following laparoscopic cholecystectomy. Cardiovasc Intervent Radiol 1996; 19:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/89\">",
"      Smith TP, McDermott VG, Ayoub DM, et al. Percutaneous transhepatic liver biopsy with tract embolization. Radiology 1996; 198:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/90\">",
"      Arnaud JP, Bergamaschi R, Serra-Maudet V, Casa C. Pancreatoduodenectomy for hemosuccus pancreaticus in silent chronic pancreatitis. Arch Surg 1994; 129:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/91\">",
"      Wagner WH, Cossman DV, Treiman RL, et al. Hemosuccus pancreaticus from intraductal rupture of a primary splenic artery aneurysm. J Vasc Surg 1994; 19:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/92\">",
"      Tareen AH, Schroeder TV. Primary aortoenteric fistula: two new case reports and a review of 44 previously reported cases. Eur J Vasc Endovasc Surg 1996; 12:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/93\">",
"      Voorhoeve R, Moll FL, Bast TJ. The primary aortoenteric fistula in The Netherlands--the unpublished cases. Eur J Vasc Endovasc Surg 1996; 11:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/94\">",
"      Voorhoeve R, Moll FL, de Letter JA, et al. Primary aortoenteric fistula: report of eight new cases and review of the literature. Ann Vasc Surg 1996; 10:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/95\">",
"      Walsh AK, Gwynn BR. Atypical aorto-enteric fistula. Eur J Vasc Endovasc Surg 1995; 9:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/96\">",
"      Saers SJ, Scheltinga MR. Primary aortoenteric fistula. Br J Surg 2005; 92:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/97\">",
"      Bergqvist D, Bj&ouml;rkman H, Bolin T, et al. Secondary aortoenteric fistulae--changes from 1973 to 1993. Eur J Vasc Endovasc Surg 1996; 11:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/98\">",
"      Kuestner LM, Reilly LM, Jicha DL, et al. Secondary aortoenteric fistula: contemporary outcome with use of extraanatomic bypass and infected graft excision. J Vasc Surg 1995; 21:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/99\">",
"      Schwab CW, McMahon DJ, Phillips G, Pentecost MJ. Aortic balloon control of a traumatic aortoenteric fistula after damage control laparotomy: a case report. J Trauma 1996; 40:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/100\">",
"      Napoli PJ, Meade PC, Adams CW. Primary aortoenteric fistula from a posttraumatic pseudoaneurysm. J Trauma 1996; 41:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/101\">",
"      Zaman A, Katon RM. Push enteroscopy for obscure gastrointestinal bleeding yields a high incidence of proximal lesions within reach of a standard endoscope. Gastrointest Endosc 1998; 47:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/102\">",
"      Ruhl CE, Everhart JE. Relationship of iron-deficiency anemia with esophagitis and hiatal hernia: hospital findings from a prospective, population-based study. Am J Gastroenterol 2001; 96:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/103\">",
"      Moskovitz M, Fadden R, Min T, et al. Large hiatal hernias, anemia, and linear gastric erosion: studies of etiology and medical therapy. Am J Gastroenterol 1992; 87:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/104\">",
"      Lin CC, Chen TH, Ho WC, Chen TY. Endoscopic treatment of a Cameron lesion presenting as life-threatening gastrointestinal hemorrhage. J Clin Gastroenterol 2001; 33:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/56/41865/abstract/105\">",
"      Panzuto F, Di Giulio E, Capurso G, et al. Large hiatal hernia in patients with iron deficiency anaemia: a prospective study on prevalence and treatment. Aliment Pharmacol Ther 2004; 19:663.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2645 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-F0948400E7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41865=[""].join("\n");
var outline_f40_56_41865=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H203638978\">",
"      UPPER GASTROINTESTINAL TUMORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H203638985\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIEULAFOY'S LESION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      GASTRIC ANTRAL VASCULAR ECTASIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PORTAL HYPERTENSIVE GASTROPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Natural history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      HEMOBILIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      HEMOSUCCUS PANCREATICUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      AORTOENTERIC FISTULAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      CAMERON LESIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H809058756\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2645\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2645|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?43/3/44095\" title=\"picture 1\">",
"      Fungating gastric cancer Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/59/35774\" title=\"picture 2\">",
"      Dieulafoys lesion Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?16/12/16582\" title=\"picture 3\">",
"      Bleeding Dieulafoy Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/61/19408\" title=\"picture 4\">",
"      GAVE endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/44/23237\" title=\"picture 5\">",
"      GAVE Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/23/30070\" title=\"picture 6A\">",
"      GAVE argon plasma Rx Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/59/40895\" title=\"picture 6B\">",
"      GAVE post bipolar probe endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/5/35935\" title=\"picture 7\">",
"      Portal hypertensive gastropathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/38/11882?source=related_link\">",
"      Adjuvant and neoadjuvant treatment of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/13/8410?source=related_link\">",
"      Angiodysplasia of the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/2/24616?source=related_link\">",
"      Angiographic control of nonvariceal gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/55/28538?source=related_link\">",
"      Approach to acute upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/56/34695?source=related_link\">",
"      Argon plasma coagulation in the management of gastrointestinal hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/10/44202?source=related_link\">",
"      Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/36/11850?source=related_link\">",
"      Clinical features, diagnosis, and staging of gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35386?source=related_link\">",
"      Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal mesenchymal neoplasms including GIST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/15/33018?source=related_link\">",
"      Invasive gastric cancer: Surgery and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/23/12664?source=related_link\">",
"      Major causes of upper gastrointestinal bleeding in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43317?source=related_link\">",
"      Mallory-Weiss syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/15/24826?source=related_link\">",
"      Overview of the treatment of bleeding peptic ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/61/25559?source=related_link\">",
"      Patient selection for liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/51/30519?source=related_link\">",
"      Tattooing and other methods for localizing colonic lesions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_56_41866="Hidradenitis suppurativa draining inflammatory nodule";
var content_f40_56_41866=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F53340%7ESURG%2F70778%7ESURG%2F50847%7ESURG%2F64990%7ESURG%2F57893%7ESURG%2F66627%7ESURG%2F81667&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F53340%7ESURG%2F70778%7ESURG%2F50847%7ESURG%2F64990%7ESURG%2F57893%7ESURG%2F66627%7ESURG%2F81667&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hidradenitis suppurativa draining inflammatory nodule",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 379px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This photograph shows an inflammatory draining nodule. The patient was diagnosed with hidradenitis suppurativa in the groin, the nodule is medial to left inguinal crease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hidradenitis suppurativa and surgical unroofing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Surgical unroofing is the primary therapy for severe and extensive hidradenitis suppurativa. This picture shows the beveled edges of the wound following the unroofing of the inflamed nodule. Ferric chloride was used to control hemostasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hidradenitis suppurativa sinus tract",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 370px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This photograph shows a sinus tract related to a hidradenitis suppurativa inflamed nodule. The tract is identified by probing the margins of the wound. The procedure is performed using a local anesthetic with epinephrine.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gauze grattage of an unroofed hidradenitis suppurativa sinus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 275px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows the unroofed inflamed hidradenitis suppurativa nodule site and sinus tract. Rough gauze grattage removes the active proliferative inflammatory mass that re-populates the tract with pilosebaceous structures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Extensive hidradenitis suppurativa with multiple sinus tracts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 397px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows the initial surgical unroofing of the inflamed hidradenitis suppurativa inflamed nodule, the lateral extension of the sinus tract, and an additional inferior lateral sinus tract. Gentle probing with blunt scissors has identified another sinus tract that requires unroofing with beveled skin edges.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hidradenitis suppurativa nodule and sinus tracts unroofed",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 270px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows the completely unroofed inflamed hidradenitis suppurativa nodule and multiple sinus tracts. Note the skin edges are beveled and the base is scraped clean of debris by rough gauze grattage. Hemostasis is controlled using ferric chloride and the wound is cleansed with hydrogen peroxide and covered with petrolatum dressing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Hidradenitis suppurativa wound healed",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows the healed wound following unroofing of an inflamed nodule and multiple sinus tracts in a patient with extensive hidradenitis suppurativa of the groin. The wound healed in four weeks, dressed with petrolatum only. In order to avoid damage to the reepithelialization process, no gauze or other dressings were used.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41866=[""].join("\n");
var outline_f40_56_41866=null;
var title_f40_56_41867="Chicago protocol for treatment of IVH";
var content_f40_56_41867=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F54351&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F54351&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    University of Illinois at Chicago protocol for intraventricular thrombolysis for IVH",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Exclusions: Unsecured aneurysm or vascular malformation, coagulopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       1. Monitor ICP continuously",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2. Withdraw CSF volume equivalent to drug volume to be administered",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       3. Inject t-PA through ventriculostomy:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       &bull; Dose: 3 to 8 mg t-PA",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       &bull; Maximum concentration: 4 mg/mL",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       &bull; Usual dose: 3 to 5 mg",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       &bull; High dose: 8 mg given for severe IVH with all ventricles affected",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       4. Flush catheter with 1 to 1.5 mL of preservative-free normal saline",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       5. Clamp EVD for 2 hours; unclamp if ICP &gt;25 mm Hg, allowing 1 to 2 mL CSF to drain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       6. After 2 hours alternate EVD open to zero gravity and EVD closed for one hour at a time for a total of 12 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       7. Follow CT scan at 12 to 24 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       8. Consider repeat t-PA administration at 12 to 24 hours depending on CT scan results",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IVH: intraventricular hemorrhage; ICP: intracranial pressure; CSF: cerebrospinal fluid pressure; EVD: endoventricular drain; CT: computed tomography.",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      Andrews, CO, Engelhard, HH. Fibrinolytic therapy in intraventricular hemorrhage. Ann Pharmacother 2001; 35:1435.",
"      <br>",
"       Engelhard, HH, Andrews, CO, Slavin, KV, Charbel, FT. Current management of intraventricular hemorrhage. Surg Neurol 2003; 60:15.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41867=[""].join("\n");
var outline_f40_56_41867=null;
var title_f40_56_41868="Pyoderma gangrenosum ddx";
var content_f40_56_41868=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F72103&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F72103&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pyoderma gangrenosum: Differential diagnosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Inflammatory papules, pustules, nodules, or plaques (early disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Folliculitis, furuncles, or carbuncles (bacterial, viral, or fungal)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cellulitis or cellulitis-like lesions (bacterial, mycobacterial, or fungal)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arthropod bite reaction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphoma (cutaneous T and B cell)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Panniculitides (inflammatory, infectious, neoplastic, metabolic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iododerma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bromoderma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Ulcers and vegetative lesions (later disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Bacterial infections - botryomycosis, streptococcal synergistic gangrene, ecthyma gangrenosum, gummatous treponemal ulcers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Fungal infections - lesions associated with deep mycosis (blastomycosis, chromomycosis , coccidioidomycosis, paracoccidioidomycosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mycobacterial infections - atypical and typical mycobacteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Parasitic infections - leishmaniasis, amoebiasis, schistosomiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Vascular disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Vasculitis - cutaneous polyarteritis nodosa, microscopic polyangiitis, granulomatous vasculitidies, autoimmune connective tissue disease, Beh&ccedil;et's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ulcers related to:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Venous hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Arterial insufficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Hemoglobinopathies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Non-septic emboli",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Hypercoagulopathic thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Malignancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Nonmelanoma skin cancer (squamous cell or basal cell carcinoma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cutaneous T or B cell lymphoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Brown recluse spider bite",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Necrobiosis lipoidica with ulceration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Blastomycosis-like pyoderma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pemphigus vegetans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Self-induced (factitial) ulcer",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Moschella, SL, Davis, MDP. Neutrophilic dermatoses. In: Dermatology, 2nd ed, Bolognia, JL, Jorizzo, JL, Rapini, RP (Eds), Mosby Elsevier, Spain 2008.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41868=[""].join("\n");
var outline_f40_56_41868=null;
var title_f40_56_41869="NYHA repair vs replacement MV";
var content_f40_56_41869=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 530px\">",
"   <div class=\"ttl\">",
"    Survival after mitral valve surgery is better for patients in NYHA class I/II independent of procedure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 510px; height: 271px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Long-term patient survival after mitral valve surgery for chronic mitral regurgitation is better in those with NYHA class I/II compared to those in class III/IV at the time of surgery. This benefit is independent of the type of procedure performed (replacement versus repair), although the outcomes are better in those undergoing repair.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Circulation 1999; 99:400.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41869=[""].join("\n");
var outline_f40_56_41869=null;
var title_f40_56_41870="Disorders with annular skin lesions";
var content_f40_56_41870=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57617&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57617&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Examples of skin disorders that may present with annular lesions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Population commonly affected",
"       </td>",
"       <td class=\"subtitle1\">",
"        Common clinical features",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pertinent histopathologic findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Peripheral scale",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tinea corporis",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Annular erythematous plaques with peripheral leading scale",
"       </td>",
"       <td>",
"        Hyphae in the stratum corneum; KOH preparation is preferred initial test",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pityriasis rosea",
"       </td>",
"       <td>",
"        Children and young adults",
"       </td>",
"       <td>",
"        Thin erythematous plaques on trunk and proximal extremities in \"Christmas tree\" pattern; may have large initial lesion (herald patch)",
"       </td>",
"       <td>",
"        Focal parakeratosis, epidermal spongiosis, perivascular lymphohistiocytic infiltrate, RBC extravasation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Superficial erythema annulare centrifugum",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Erythematous plaques with trailing scale on face, trunk, or extremities",
"       </td>",
"       <td>",
"        Parakeratosis, spongiosis, superficial intense perivascular lymphohistiocytic infiltrate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Porokeratosis",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Plaque with very thin rim of scale at periphery; multiple clinical variants exist",
"       </td>",
"       <td>",
"        Cornoid lamella - thin column of parakeratosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Vesicles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Linear IgA bullous dermatosis",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Annular clusters of tense bullae on an inflammatory base",
"       </td>",
"       <td>",
"        Subepidermal bullae with neutrophilic infiltrates; direct immunofluorescence reveals linear deposits of IgA at the DEJ",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Pustules",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Subcorneal pustular dermatosis",
"       </td>",
"       <td>",
"        Most common in adults over 40",
"       </td>",
"       <td>",
"        Intertriginous and flexural flaccid pustules and crusted plaques",
"       </td>",
"       <td>",
"        Subcorneal pustules with neutrophils",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Purpura",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Purpura annularis telangiectodes of Majocchi",
"       </td>",
"       <td>",
"        Most common in young women and female adolescents",
"       </td>",
"       <td>",
"        Round patches on the lower extremities that do not blanch with pressure",
"       </td>",
"       <td>",
"        Perivascular lymphocytic infiltrates and extravasated erythrocytes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Acute hemorrhagic edema of infancy",
"       </td>",
"       <td>",
"        Children under the age of two",
"       </td>",
"       <td>",
"        Urticarial plaques progressing to purpuric plaques",
"       </td>",
"       <td>",
"        Leukocytoclastic vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Henoch-Sch&ouml;nlein purpura",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Palpable purpura on the lower extremities; arthritis, abdominal pain, and hematuria may be present",
"       </td>",
"       <td>",
"        Leukocytoclastic vasculitis; direct immunofluorescence reveals IgA deposits in vessel walls",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urticarial vasculitis",
"       </td>",
"       <td>",
"        Most common in adult women",
"       </td>",
"       <td>",
"        Urticarial plaques that last more than 24 hours with or without purpura or hyperpigmentation; burning sensations or pain may be present",
"       </td>",
"       <td>",
"        Leukocytoclastic vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Traumatic purpura",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Annular ecchymosis or purpura",
"       </td>",
"       <td>",
"        Hemorrhage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dependent purpura in annular inflammatory disorders",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Annular purpura on lower abdomen and legs, non-purpuric primary lesions are often present elsewhere",
"       </td>",
"       <td>",
"        Dependent on the underlying disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Expanding lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tinea corporis",
"       </td>",
"       <td colspan=\"3\">",
"        See \"Peripheral scale\" above",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Erythema migrans (Lyme disease)",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Large erythematous plaque that rapidly expands",
"       </td>",
"       <td>",
"        Superficial and deep lymphocytic infiltrate with plasma cells and eosinophils; spirochetes are sometimes detectable",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Granuloma annulare",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Non-scaly plaque with a dull erythematous color; often found on distal extremities",
"       </td>",
"       <td>",
"        Palisading granulomas or interstitial histiocytes plus increased mucin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Superficial erythema annulare centrifugum",
"       </td>",
"       <td colspan=\"3\">",
"        See \"Peripheral scale\" above",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Deep erythema annulare centrifugum",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Erythematous plaques without scale on face, trunk, or extremities",
"       </td>",
"       <td>",
"        Superficial and deep intense perivascular lymphocytic infiltrate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum sickness-like reaction",
"       </td>",
"       <td colspan=\"3\">",
"        See \"Associated fever\" below",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Migratory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urticaria",
"       </td>",
"       <td>",
"        Children and adults",
"       </td>",
"       <td>",
"        Pink edematous plaques (wheals)",
"       </td>",
"       <td>",
"        Dermal edema, mild perivascular lymphocytic infiltrate with occasional eosinophils, mast cells, and neutrophils",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Erythema marginatum",
"       </td>",
"       <td>",
"        Most common in children; occurs in rheumatic fever due to group A streptococcal infection",
"       </td>",
"       <td>",
"        Erythematous, polycyclic patches or plaques that migrate within hours",
"       </td>",
"       <td>",
"        Superficial perivascular neutrophilic infiltrate with a few lymphocytes and eosinophils",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Photodistributed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Subacute cutaneous lupus erythematosus",
"       </td>",
"       <td>",
"        Most common in adult women; approximately 50 percent meet criteria for SLE",
"       </td>",
"       <td>",
"        Erythematous, scaly plaques",
"       </td>",
"       <td>",
"        Lymphocytic interface dermatitis, dermal edema, mucin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lupus erythematosus tumidus",
"       </td>",
"       <td>",
"        Most common in adult women",
"       </td>",
"       <td>",
"        Erythematous plaques with minimal epidermal change",
"       </td>",
"       <td>",
"        Superficial and deep perivascular and periadnexal lymphocytic infiltrates with mucin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Neonatal lupus erythematosus",
"       </td>",
"       <td>",
"        Infants up to four months of age",
"       </td>",
"       <td>",
"        Polycyclic erythematous plaques; may be accompanied by cardiac abnormalities",
"       </td>",
"       <td>",
"        Lymphocytic interface dermatitis, dermal edema, mucin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Actinic lichen planus",
"       </td>",
"       <td>",
"        Most common in dark-skinned young adults; particularly those of Middle-Eastern descent",
"       </td>",
"       <td>",
"        Hyperpigmented plaques are often located on the face, forearms, or dorsal hands",
"       </td>",
"       <td>",
"        Hyperkeratosis, hypergranulosis, interface dermatitis; similar to classic lichen planus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Acral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Erythema multiforme",
"       </td>",
"       <td>",
"        Most frequent in young adults, but occurs at all ages; commonly associated with HSV",
"       </td>",
"       <td>",
"        Target and atypical target lesions with a predilection for acral sties; mucous membrane involvement is common",
"       </td>",
"       <td>",
"        Interface dermatitis, dense superficial lymphohistiocytic infiltrate in dermis, clefts and vesiculation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Granuloma annulare",
"       </td>",
"       <td colspan=\"3\">",
"        See \"Expanding lesions\" above",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Genital",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Erythema multiforme",
"       </td>",
"       <td colspan=\"3\">",
"        See \"Acral\" above",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Circinate balanitis in reactive arthritis",
"       </td>",
"       <td>",
"        Most common in young men; associated with HLA-B27",
"       </td>",
"       <td>",
"        Moist annular or serpiginous papules or erosions; also may have conjunctivitis, urethritis, and arthritis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Annular lichen planus",
"       </td>",
"       <td>",
"        Most common in men",
"       </td>",
"       <td>",
"        Annular plaques on the penis or scrotum; may also occur on nongenital body sites",
"       </td>",
"       <td>",
"        Hyperkeratosis, hypergranulosis, and interface dermatitis as in classic lichen planus; elastolysis in atrophic lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Associated fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Acute febrile neutrophilic dermatosis (Sweet syndrome)",
"       </td>",
"       <td>",
"        Most common in adult females",
"       </td>",
"       <td>",
"        Erythematous, edematous, juicy plaques on upper body",
"       </td>",
"       <td>",
"        Dense neutrophilic infiltrate in superficial dermis, leukocytoclasis, prominent edema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum sickness-like reaction",
"       </td>",
"       <td>",
"        Children and adults; often follows antibiotic therapy",
"       </td>",
"       <td>",
"        Urticarial plaques, usually slowly expanding and colliding with neighboring lesions to make polycyclic whealed plaques",
"       </td>",
"       <td>",
"        Leukocytoclastic vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Acute hemorrhagic edema of infancy",
"       </td>",
"       <td colspan=\"3\">",
"        See \"Purpura\" above",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Kawasaki's disease",
"       </td>",
"       <td>",
"        Children under the age of five",
"       </td>",
"       <td>",
"        <p>",
"         Usually an exanthematous eruption, but occasionally presents with targetoid lesions",
"        </p>",
"        <p>",
"         Conjunctivitis, mucositis, acral edema, and lymphadenopathy may be present",
"        </p>",
"       </td>",
"       <td>",
"        Nonspecific findings such as edema in the superficial dermis, mild perivascular lymphocytic changes; vasculitis is rare",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     KOH: potassium hydroxide; RBC: red blood cell; DEJ: dermal-epidermal junction; SLE: systemic lupus erythematosus; HSV: herpes simplex virus.",
"     <br>",
"      * Annular lesions may present as an occasional finding in many other skin disorders, such as psoriasis, nummular dermatitis, seborrheic dermatitis, secondary syphilis, sarcoidosis, mycosis fungoides, and malignant skin tumors.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41870=[""].join("\n");
var outline_f40_56_41870=null;
var title_f40_56_41871="Nexplanon insertion";
var content_f40_56_41871=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1124px;\">",
"  <div class=\"videoplayer\" h264=\"./images/OBGYN/77440/Nexplanon_insertion_video.mp4?title=Nexplanon+insertion\" style=\"width:480px;height:368px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Nexplanon insertion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission of MSD Oss B.V., a subsidiary of Merck &amp; Co., Inc., Whitehouse Station, New Jersey, USA. All rights reserved. NEXPLANON is a registered trademark of MSD Oss B.V. All requests to reproduce this copyrighted material should be directed to MSD Oss B.V.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_56_41871=[""].join("\n");
var outline_f40_56_41871=null;
